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“The mycobacteriophage Bxb1 integrase as a catalyst for DNA inversion in 
Saccharomyces cerevisiae” 
Authored by Marshall Timmermans 
Synthetic biology aims to develop methods of genetic regulation not seen in 
nature to manipulate biological systems, allowing them to achieve incredibly complex 
feats of biotechnology. One genetic element which has been receiving some attention 
by synthetic biologists is a class of enzymes known as serine recombinases. These 
enzymes have been shown to catalyze integration, excision, and inversion of DNA in a 
site-specific and directional manner. Due to the variety of activities of these enzymes 
and their irreversible mechanism of action, these enzymes could be used to construct 
gene regulation devices analogous in function to the digital memory of modern 
computers. This “genetic memory” could potentially offer improvements to the field of 
metabolic engineering and industrial biotechnology. This thesis aims to explore the use 
of DNA inversion catalyzed by the serine integrase from the BXB1 mycobacteriophage 
as a method of gene control in the brewer’s yeast Saccharomyces cerevisiae. Three 
assays were developed wherein a yeast-enhanced Green Fluorescent Protein (yeGFP) 
coding sequence could be inverted with respect to a promoter to determine the 
parameters of the BXB1 integrase inversion in yeast. The results from these assays 
show that this reporter system could be made to “activate” GFP fluorescence on a 
plasmid, but could not be found to inactivate GFP fluorescence on a plasmid or activate 
the chromosomally integrated GFP reporter. These results, call into serious question the 
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utility of the BXB1 serine integrase, and possibly serine integrases in general, as tools 
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CHAPTER 1: INTRODUCTION 
1.1: TOOLS FOR MODULATING GENE EXPRESSION IN SYNTHETIC BIOLOGY AND 
METABOLIC ENGINEERING  
Synthetic biology is a relatively novel sub-discipline of biotechnology, which aims 
to rationally engineer gene expression in living systems to create novel emergent 
behaviours generating new patterns of gene expression based on chemical inputs and 
biological outputs.1 Due to recent advances in technology related to DNA sequencing, 
synthesis, and cloning, the ability to rationally engineer complex biological systems that 
can be modelled with a high degree of predictability has advanced the field of 
biotechnology to levels unimagined even a few years ago. One area of synthetic biology 
focuses on refactoring existing biological signalling pathways to produce gene 
expression behaviours not found in nature. Stable oscillation of gene expression in 
response to chemical feedback loops,2 “logic gate” or computational expression of 
multiple genes in response to various environmental stimuli,3 and the optimization of 
transgenic multi-enzyme metabolic pathways through the differential transcript-level 
regulation of each step in that pathway4 are all examples of such engineered systems.  
Metabolic engineering is the practice of genetically engineering organisms to 
produce high quantities of enzymatically synthesized small molecules and 
macromolecules.5  This practice, like more theoretical aspects of synthetic biology, is 
concerned with specifically and differentially expressing enzymes in order to direct the 
flow of intracellular metabolites towards a desired product. One common property 
between synthetic biology and metabolic engineering is the desire to control the 
expression of multiple genes simultaneously within a living organism. However, the 
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most complex of these synthetic gene regulatory systems have been developed in 
bacteria such as Escherichia coli and Bacillus subtilis.6 The differences in structure and 
complexity between prokaryotic and eukaryotic gene regulation mean that advances in 
synthetic biology research focusing on prokaryotic organisms cannot necessarily be 
directly applied to eukaryotes, and the engineering of complex phenotypes in 
eukaryotes has lagged behind prokaryotic engineering in terms of sophistication.6 
Having a diverse toolbox of these genetic mechanisms applied to organisms more 
suitable for industrial fermentation, such as Saccharomyces cerevisiae, would provide 
additional tools for molecular biologists and genetic engineers to perform complex 
manipulations of living systems.  
1.1.1: METABOLIC FLUX AND INDUCIBLE VS CONSTITUTIVE PROMOTERS  
Microbial production of important molecules has long been faced with a serious 
problem when it comes to expressing genes that are detrimental to the health of the 
microbe producing it. The strategy of overexpressing a gene product by regulating the 
gene under the power of a strong constitutive promoter may be suitable for the microbial 
production of many gene products, but if the gene product in question inhibits the 
growth of the microbe then constitutive expression of the gene product will make large-
scale production of that molecule impractical. For example, heterologous expression of 
the Xanthophyllomyces dendrorhous carotenoid biosynthetic pathway in S. cerevisiae 
was found to induce cell membrane stress and triggered the pleiotropic drug resistance 
response, which slowed cell growth substantially compared to un-engineered S. 
cerevisiae.7 Similarly, heterologous expression of the antimalarial drug precursor 
artemisinic acid pathway in yeast initially resulted in decreased stability of the plasmid 
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expressing this pathway, and induced oxidative and osmotic stress responses as well 
as the pleiotropic drug response in addition to reducing the cellular growth rate.8 When 
growth of the microbe in fermentation is inhibited, the total yield of the desired product 
will be limited. The solution in the case of heterologous production of proteins in E. coli 
or yeast has been generally accepted to be to regulate the gene responsible for the 
toxic product under the power of an inducible promoter, such as the promoter from the 
E. coli Lac operon, or the yeast GAL1 galactose-inducible promoter.9 In this way cell 
division of the production microbe can occur unimpeded by the presence of the toxic 
gene product until the culture has reached a high density, after which expression of the 
toxic gene product can be induced and the quantity of gene product resulting from the 
fermentation can be increased compared to a constitutive expression strategy. 
 The inducible promoters used in these types of fermentation have their 
disadvantages. Chemicals such as Isopropyl β-D-1-thiogalactopyranoside (IPTG), a 
synthetic analogue of lactose used to induce the Lac promoter in E. coli, can be 
expensive when applied in large-scale bioreactors, raising the cost of large-scale 
fermentation of strains bearing Lac-regulated genes of interest. Promoters dependent 
on non-glucose carbohydrates, changes in pH, or changes in temperature may alter the 
growth of the production strain in undesirable ways10 and may be difficult to implement 
in large scale bioreactors. Engineering gene expression strategies, which do not perturb 
the growth of the production strain, should therefore be a goal of genetic engineers 
seeking to maximize microbial production of potentially toxic gene products. 




One of the major approaches towards balancing metabolic flux through a 
pathway focuses on steady-state engineering of gene expression by combinatorial 
optimization of enzyme expression levels in order to characterize and optimize 
metabolite production. This is done by discovering or engineering libraries of 
constitutive promoters of varying strengths, by discovering or engineering variants of 
other genetic elements such as ribosome binding sites with different strengths, or by 
differentially controlling the copy number of DNA coding for metabolically active 
enzymes. Using these expression level variants libraries of strains expressing different 
levels of each enzyme in a metabolic pathway are generated that can be used to 
determine the optimal flux through that pathway.11–13 This approach has been applied 
towards generating strains of S. cerevisiae expressing a heterologous xylose utilization 
pathway, directing flux of carbon from xylose towards ethanol production without 
compromising cell growth.14 This combinatorial approach has also been successful in 
optimizing a 6-gene pathway for the production of farnesyl pyrophosphate (FPP) in E. 
coli through combinatorial engineering of ribosome binding sites of various strengths.15 
An approach towards combinatorial optimization of a heterologous mevalonic acid 
biosynthetic pathway in S. cerevisiae was capable of increasing production of amorpha-
4,11, diene (a precursor for the antimalarial drug artemisinin) through integration of 
multiple copies of each biosynthetic gene in this pathway into the S. cerevisiae 
chromosome through δ-integration.16 While there is a distinct advantage to this 
approach of combinatorial optimization, in that generating a random library can be 
achieved by transforming a strain with a mix of DNA elements to create a random 
library, there are also some disadvantages. Depending on the number of biosynthetic 
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genes that an experimenter may want to modulate, and depending on the number of 
promoter elements used to vary expression of each step, the libraries generated in 
these experiments can grow to be quite large, and the only way to determine whether 
the experiment has worked is to screen as many of the variants as possible. There is 
another disadvantage in that if the regulatory elements used to generate the 
combinatorial library are constitutive, there may be some combinations of expression 
levels that are lethal to the cell. These lethal variants may provide useful insight into the 
chemistry of the pathway, but obtaining direct information about these variants may not 
be simple due to the inherent bias in the library generation process. Engineering 
systems of genetic expression that are precisely controllable, rather than constitutive, 
would go a long way towards addressing this bias. 
1.1.3: DYNAMIC CONTROL OF METABOLIC FLUX USING BIOSENSORS  
Another approach to metabolic optimization is to engineer metabolic control of a 
heterologous pathway through the use of biosensors and feedback loops.17 Biosensor in 
this context refers to a protein or RNA molecule that is capable of specific allosteric 
binding to some small molecule metabolite, synthetic small molecule, or metal ion, and 
this binding instigates some change in the expression or activity of another gene or 
protein.18 The principle behind this approach is that it is possible to discover or engineer 
a biosensor capable of recognizing some indicator of the concentration of specific 
metabolite within a cell. This biosensor would then either provide some quantitative 
measure of the metabolic flux towards the desired product such as through the 
generation of pigments or fluorogenic compounds allowing for high-throughput non-
chemical screening of genetic variants of the desired biosynthetic pathway, or by 
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altering the expression of some point(s) of that pathway in order to increase flux toward 
the desired product.19 This approach to metabolic engineering adds an element of 
temporal control over the expression of biosynthetic genes, allowing for a dynamic 
response to changes in the intracellular metabolite profile of the cell or changes in the 
extracellular environment. One illustrative example of this strategy is overproduction of 
the heterologous lycopene pathway in E. coli through incorporation of the E. coli Ntr 
regulon into the heterologous lycopene pathway.20 This regulon in E. coli is capable of 
sensing the intracellular concentration of acetyl phosphate (ACP), which was seen as 
an indicator of glucose availability for pathways other than lycopene. By regulating the 
expression of two rate-limiting steps in the lycopene pathway under the power of the 
glnAp2 promoter, a response element of the Ntr regulon, such that the expression of 
these lycopene synthetic enzymes would increase whenever concentrations of ACP 
increased above some threshold. This achieved a feedback loop between lycopene 
production and biomass accumulation capable of finding some balance between the 
fluxes of these two processes.  
The application of biosensors to form the sort of “closed loop” feedback 
mechanisms, where a feedback mechanism is able to both sense a metabolite related 
to the metabolic process being modified and directly affect the expression of that 
pathway, has been limited in the years following the publishing of the Ntr lycopene 
biosensor.18 Part of the difficulty in developing true closed loop biosensors is in 
generating a sensor that is able to directly affect expression of the pathway that it 
senses. So called “open loop” biosensors which allosterically bind to some inducer not 
related to the pathway being engineered and then affect some change in activity or 
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expression of that pathway have been identified as possible tools for specific 
modulation of the activities of multiple enzymes in a pathway, for example by controlling 
flux through the Embden-Meyerhof, Entner-Doudoroff, and pentose phosphate 
pathways in E. coli through control of the extracellular concentrations of iron, 
magnesium, and quorum sensing molecules.21 The open loop approach to biosensors 
does not provide the sort of autonomous dynamic control provided by the closed loop 
example, but still enable experimenters to manually fine tune the expression of multiple 
steps in a biosynthetic process. Biosensors also show promise in enabling high-
throughput screening of directed evolution and protein engineering experiments, which 
aim to increase flux through a pathway. Biosensors have been developed that sense 
some metabolite in a biosynthetic pathway and produce a fluorometric or colourimetric 
indication of that metabolite’s concentration, thus allowing experimenters to use high 
throughput fluorometry or spectrophotometry in place of relatively low-throughput 
chromatographic or mass-spectrometry based screening in order to determine 
metabolite concentration.22 This can involve generating whole cell sensors in the form of 
auxotrophic strains expressing a fluorescent protein, which will “sense” the presence of 
the molecule that they are auxotrophic for by continuing to grow and express the 
fluorescent protein,23 or by identifying regulons that allosterically bind to a small 
molecule and directly induce expression of some reporter molecule.24  One such 
example was the creation and utilization of an intracellular methionine and valine 
transcription factor based biosensor capable of inducing expression of green fluorescent 
protein (GFP), which enabled the imposition of artificial selection by fluorescence 
associated cell sorting (FACS) during a random mutagenesis directed evolution 
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experiment attempting to overproduce the essential amino acid L-valine.25 A propionate 
biosensor coupled to the expression of GFP was also used to enable the heterologous 
expression of the CO2-fixing 3-hydroxyproprionate pathway from Chloroflexus 
aurantiacus in E. coli, which required expression and mutagenesis of four metabolic 
pathways and several deletions in the host strain in order to succeed.26 Biosensors 
needn’t always involve allosteric binding of metabolites to some transcription effector 
protein in order to provide an indication of the metabolic state of a cell. By expressing a 
DOPA dioxygenase from the flowering plant Mirabilis jalapa in S. cerevisiae, which 
produces the purple pigment betaxanthin from DOPA, experimenters were able to 
create a biosensor indicating the flux of carbon towards the dopamine pathway.27 This 
enabled the rapid characterization of around 200,000 tyrosine hydroxylase mutants by 
monitoring the appearance of the coloured pigment as a proxy for tyrosine hydroxylase 
activity and allowing for the downstream production of high titers of (S)-reticuline from a 
heterologous pathway in yeast.  
In all cases, biosensors appear to offer significant advantages for metabolic 
engineering, although generating a specific biosensor is non-trivial and entirely depends 
on the chemical and biological context of the metabolite being detected, and so far the 
potential of closed-loop true feedback systems has yet to be realized. The ability to 
detect metabolites without having to subject cultures to low-throughput chemical 
analysis in order to determine the metabolic state of a cell is currently one of the most 
useful, and most used application of biosensors. 




 In addition to transcriptional manipulation for metabolic optimization, it is also 
possible to control metabolic flux at the protein level by altering the stability of enzymes 
in a biosynthetic pathway. By increasing the half-life of weakly expressed or weakly 
functional enzymes in a pathway, or by reducing the half-life of problematic enzymes in 
a pathway, the overall abundance of that enzyme in the host cell can be manipulated to 
optimize metabolic flux. This can be achieved by creating fusion proteins of some 
metabolic enzyme tagged with peptide sequences, which will target that enzyme for 
degradation or prevent it from being degraded. Increasing the stability of a weakly 
functional enzyme, MIOX, in a heterologous three-enzyme α-D-glucaric acid pathway in 
E. coli by appending an N-terminal SUMO tag, which prevents ubiquitination, resulted in 
a twofold increase in the conversion of this product from glucose.28 Reducing the 
stability of phosphofructokinase has been achieved in E. coli by generating fusions of 
phosphofructokinase with an SsrA tag, which can target that enzyme for degradation 
upon the induction of expression of the SsrB adaptor protein; the result being an 
inducible reduction in the rate of central metabolism and the diversion of carbon flux 
towards the myo-inositol synthesis pathway in a strain with a stable glucose-6-
phosphate 1-dehydrogenase (zwf) knockout.29 Engineering protein stability for 
metabolic engineering is a strategy that has been shown to be effective in these and 
numerous other contexts, but does suffer from the drawback of all protein fusion 
experiments in the effect of the fusion tag on the specific activity of the enzyme must be 
determined experimentally for each enzyme fusion. 
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1.2: ENGINEERING GENETIC MEMORY  
 One recent development in the field of synthetic biology may result in 
better induction strategies for large scale fermentation of microbes bearing engineered 
metabolic pathways, namely the concept of “Genetic Memory”.3,30 The general concept 
of genetic memory is that expression of a gene is induced in a permanent, rather than 
transient, manner. The use of the term “memory” is an analogy to digital information 
storage, not cognitive or neurological memory, in that genetic expression can be 
bistable in the sense of being either on or off and remaining in that state until some new 
stimulus causes it to change states again. This concept of genetic memory could 
potentially have applications in the field of metabolic engineering complimentary to 
inducible systems of metabolic control, such as open loop biosensors. For large-scale 
fermentation of inducible gene products, traditional induction requires that the induction 
conditions must be maintained throughout the entire production phase of the 
fermentation. Inducers, which are also carbon sources for the microbe, such as 
galactose, must be continually added to the fermentation media as the microbe 
consumes it. Even for non-metabolized inducers such as IPTG or acyl homoserine 
lactones (AHL), they must be added continuously to the fermentation media to replace 
inducer, which may be chemically inactivated. These features of inducer kinetics may 
lead to inefficiencies in product formation, particularly in the case of small molecules 
rising from multi-enzyme bioconversion pathways where factors such as metabolic 
burden and redox imbalance already limit product formation. 
In contrast to traditional inducible promoters, gene expression systems based on 
the concept of genetic memory would provide an irreversible change in expression 
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levels upon addition of an inducer which is maintained after the inducer is taken away. 
Figure 1-1 shows an example of a hypothetical yeast strain expressing some valuable 
product from a cassette regulated a traditional promoter compared to a strain with 













Figure 1-1: Hypothetical effects of Genetic Memory on metabolite production in microbial culture. A: 
Situation where some metabolite product is expressed constituitively and whose concentration 
increases in tandem with the cell number of the production strain. B: Case where the metabolite 
product is inhibitory or toxic to the cell,  the growth rate of the cell is limited by the production of the 
product. C: Where that toxic product is regulated by an inducible promoter, cell growth can occur 
unimpeded, but decreases upon induction. Inducer concentration must be maintained throughout the 
production phase of the fermentation. D: If the product is regulated by an irreversible genetic memory 
system, a metabolizable inducer such as galactose can be pulsed in the fermentation media, without 






























For the transient promoter, an inducer would have to be added continuously to 
the fermentation media throughout the course of production. In the case of the 
galactose-inducible GAL1 promoter of S. cerevisiae, for example, this would mean a 
permanent shift towards using galactose as a carbon source exclusively, which may be 
undesirable. For an expression cassette with genetic memory, the switch to galactose 
need only be temporary before switching back to a different carbon source, and the 
effects of the galactose induction would persist in the absence of galactose. In the case 
of non-metabolized inducers, such as IPTG or AHLs, adding sufficient inducer to a large 
scale fermentation of a strain with a transient induction system may be costly. In a 
system with genetic memory, it is possible that far lower concentrations of inducer may 
result in the same effect, as the concentration of inducer would only need to cross a 
minimum threshold to instigate the genetic memory. If a genetic memory system could 
be broadly applied to any inducible promoter system, then inducible promoters could be 




Attempts have been made to engineer genetic memory in bacteria based on 
irreversible modification of DNA by Site Specific Recombination (SSR).30–32 SSR is a 
widespread mechanism of DNA modification that serves many functions, such as a 
required in small quantities to create an induction effect equivalent to higher concentrations of inducer 
for a transient inducible promoter.  
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component of the life cycle of many viruses,33 reorganization of genomic information 
through transposition,34 and altering expression of genes through structural DNA 
modification known as phase variation.35 Generally speaking, SSR refers to directed, 
irreversible or selectively reversible recombination of double stranded DNA between two 
specific recombination sequences, catalyzed by a recombinase enzyme.  
Recombinases can be divided into two main categories based on their catalytic 
residue and mechanism of molecular action, the tyrosine and the serine recombinases. 
Both classes of enzymes have cognate DNA binding sequences, although there is little 
sequence similarity between the binding sites of even closely-related recombinases.36 
There are three types of SSR activities found in nature: Integration, Excision, and 
Inversion of DNA. The Large Serine-Type Recombinase (LSTR) integrases are a 
subclass of serine integrases, of which the mycobacteriophage BXBInt protein is a 
member is the focus of this thesis.  Many examples of LSTRs have been identified 
showing all three SSR activities to some degree.31 The ability of the LSTP integrases to 
show multiple activities is based on the non-repetitive nature of the cognate DNA 
binding sequences of these proteins. Depending on the orientation of these attachment 
sequences and the presence of accessory proteins, DNA can be either integrated, 
excised, or inverted.37 There have been around 80 LSTRs characterized so far and 
expression of these enzymes in E. coli have identified 13 including BXBInt, which show 
a high degree of orthogonality with regard to each other.38 The variety and orthogonality 
of these enzymes have led to them being incorporated into complex computational 
genetic devices which modify E. coli plasmids.31 While the utility of these computational 
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devices may currently be speculative, the use of LSTRs to alter gene expression both 
inducibly and irreversibly may have useful applications for metabolic engineering. 
 There are a number of features of serine integrases that would make them useful 
tools for molecular biology and biotechnology. Firstly, the activity of serine integrases is 
meant to be irreversible. Once recombination has been catalyzed there is little or no 
detectable reversal of that recombination, due to the fact that the DNA sequences to 
which the enzyme binds in order to catalyze recombination are not identical to each 
other and thus these sequences are destroyed during recombination. This could be 
considered a form of genetic memory, resulting in permanent modification of DNA from 
one state of inversion to another. Genetic memory could provide two main advantages 
over transient induction. Inducers such as alternative sugars, increased temperature, or 
changes in acidity can affect global gene expression patterns throughout the organism, 
which may alter how the microbe grows in undesirable ways. By allowing a gene 
expression cassette to switch states irreversibly in the presence of an inducer, the 
inducer may be removed while still allowing for the expression of the gene of interest 
and allowing for a more wild-type gene expression profile for the organism. 
 Secondly, the number of serine integrase family members, combined with the 
orthogonality of their activity, would allow experimenters to differentially regulate a 
number of genes in a complex metabolic pathway. Serine integrases are purported to 
catalyze inversion between DNA sequences known as Attachment (Att) sites named 
AttB and AttP sites as substrates regardless of what the sequence of the surrounding 
and intervening DNA is, so it is conceivable that a coding sequence could be “flipped 
on” while another coding sequence is simultaneously “flipped off”. This would require 
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only that the two coding sequences were cloned in a particular orientation with respect 
to a promoter, and that different serine integrases and their cognate Att sites regulated 
them. This type of system could potentially be useful in solving a number of problems 
unique to metabolic engineering, such as diverting metabolic flux towards a desired 
pathway by simultaneously upregulating the desired pathway and downregulating 
competing pathways, or by ablating expression of an enzyme resulting a toxic 
intermediate while simultaneously upregulating an enzyme that detoxifies that 
intermediate, or by the creation of “oscillating” patterns of gene expression where a 
heterologous pathway can be self-limiting through the expression of serine integrases 
and their cognate RDFs. 
 Thirdly, the ability of LSTR recombinases to catalyze recombination 
absent requirements for cofactors or host factors has made them popular for 
heterologous site-specific recombination. Frequently, LSTRs are monopartite enzymes 
that do not require host factors or multimerization in order to catalyze integration,37 
potentially making them ideal as tools for genetic manipulation. BXB1Int can catalyze 
chromosomal integration in a diversity of organisms such as human fibroblast cells,39 
Drosophila,40 Nicotiana,41 and wheat.42 Interestingly, BXBInt can also catalyze 
unidirectional excision of tobacco chloroplast DNA,43 Arabidopsis chromosomal DNA,44 
wheat chromosomal DNA,42 and murine embryonic stem cell chromosomal DNA.45 The 
successful heterologous expression of this enzyme in particular is encouraging for the 
use of this enzyme in S. cerevisiae. 




 Integration by SSR occurs between two molecules of dsDNA, where 
recombination between two attachment sites, cause the two molecules to be spliced 
into one. The sequence of the phage BXB1 attachment sites is shown in Figure 1-2 and 
a schematic representation of the integration activity of LSTRs is shown in Figure 1-3. 
 
Figure 1-2: Attachment (Att) sites of BXB1 Integrase (BXBInt). The pre-recombination sites AttB and 
AttP share a core octonucleotide, each flanked by distinct palindromic sequences. Post recombination, 
the sites AttR and AttL are composed of elements of both AttB and AttP, but are distinct from the pre-
recombination sites and are no longer palindromic. The structure of these sites contribute to the 





Figure 1-3: Proposed mechanism of LSTR mediated integration of circularized DNA into a 
chromosome. The integrase enzyme will specifically bind to its cognate binding sites, called Att sites on 
the plasmid (hashed lines) and chromosome (dark grey). Once bound to both sites the enzyme 
catalyzes recombination between strands, forming two new sequences composed of elements from 
each of the attachment sites and a single molecule of integrated DNA. 
 
Many viruses use SSR as a method of integrating dsDNA copies of their genome 
into the chromosome of their host. For the LSTRs the principal components required for 
integration are the recombinase enzyme, and for two Att sites to exist on two separate 
molecules of DNA such as the phage genome and the genome of the host.36  Of the 
19 
 
many examples of LSTR currently characterized, the INT protein from the 
mycobacteriophage BXB1 (BXBInt) shows particular promise as a genome engineering 
and synthetic biology tool.39 BXBInt is a ~57 kDa monopartite serine recombinase of 
500 amino acids of which the N-terminal 150 amino acids comprise the catalytic domain 
bearing the active serine residue.46,47 BXBInt irreversibly and unidirectionally catalyzes 
recombination between two short (45-52) base pair DNA sequences known as AttP and 
AttB without the need for accessory proteins, host proteins, high-energy cofactors, 
divalent metals, or supercoiled DNA48,49 . As diagrammed in Figure 1-3, this enzyme will 
bind to AttP and AttB sites on two molecules of DNA, and then catalyzes strand 
exchange between these two sites to splice them together. BXBInt is highly specific to 
its cognate Att sites, as even single point mutations at almost any nucleotide position of 
either Att site will reduce binding of the enzyme to the DNA substrate and inhibit 
synapsis.50 The cognate Att sites for BXBInt are short compared to the recombination 
sites of some other serine and tyrosine recombinases. AttB is 45 base pairs and AttP is 
52 base pairs. These sites share a non-palindromic core sequence of 8 nucleotides 
which is the location of strand exchange during synapsis, and which are flanked by 6 
base pair inverted repeats.48 Outside of these inverted repeats both AttB and AttP are 
non-symmetrical and non-palindromic and thus have a distinct orientation, although 
integration occurs regardless of the orientation of the sites.48 The asymmetric nature of 
the AttB and AttP sites also contribute to the directionality of recombination activity. 
Post-recombination, the AttB and AttP sites will resolve into two distinct sequences, 
called AttR and AttL, which share the common core sequence of 8 base pairs of the 
pre-recombination sites, but whose inverted repeats and external sequences will be a 
20 
 
hybrid of both pre-recombination sites. The specificity of sequence recognition and 
proofreading of BXBInt is such that recombination will not be catalyzed between the 
AttR and AttL sites to any measurable degree.49 The irreversible nature of BXBInt 
mediated recombination is sometimes referred to as highly directional recombination, a 




 Excision is in some regards the reverse process of integration. Two 
recombination sites on one strand of DNA recombine to remove the intervening DNA 
sequence from the whole, resulting in two molecules of DNA. Excision, like integration, 
is an essential part of the life cycle of many viruses, particularly lysogenic 
bacteriophages, which will excise their dsDNA genome in preparation for encapsidation. 
Excision also function in many other contexts, such as transposons in bacterial and 
eukaryotic genomes which show excision and integration SSR independent of viral 
replication.34 The mechanism by which LSTRs catalyze excision is similar in many 
respects to the mechanism of inversion, and understanding the mechanism of excision 
may give insights to the process of inversion, which is the focus of this thesis. 
Excision mediated by LSTRs such as BXBInt can occur in two ways, both of 






Figure 1-4:  Illustration of the two mechanisms LSTR mediated Excision. RDF mediated excision is 
shown on the left. Two post-integration sites, AttR and AttL are shown as grey boxes. The integrase will 
bind to AttR and AttL, forming a loop of the intervening DNA but not catalyzing recombination. The RDF 
protein will then bind to the nucleoprotein complex formed by the Integrase, AttR and AttL. Once 
bound, the RDF will alter the function of the integrase to enable it to catalyze recombination between 
AttR and AttL, resulting in excision of the intervening DNA.  
     RDF independent excision is shown on the right. The two pre-recombination sites AttB and AttP are 
shown as grey triangles to indicate their orientation with respect to each other. When AttB and AttP are 
in this parallel orientation, Excision can occur without an RDF. This mechanism of excision also 
depends on the formation of a loop when the integrase binds to AttB and AttP, after which 




The mechanism of excision used during the BXB1 phage life cycle occurs after 
integration between AttB and AttP has occurred, and uses the post-recombination 
sequences AttR and AttL as substrates. When both AttR and AttL are on the same 
molecule of DNA, BXBInt will bind to these sites in conjunction with an accessory 
protein known generally as a Recombination Directionality Factor (RDF), which in the 
case of BXB1 is named gp47.  This RDF binds to the BXBInt / Att site DNA complex, 
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stimulating strand exchange in BXBInt / AttR + AttL complexes and inhibiting 
integration.51 The recombination between AttR and AttL will reconstruct the AttP and 
AttB sites.50 It should be noted that in order for recombination to occur between AttR 
and AttL sites on one molecule of DNA, the intervening DNA must form a loop in order 
to bring AttR and AttL into proximity with BXBInt, although it is not clear as to whether 
this loop forms stochastically, whether BXBInt mediates the formation of this loop, or 
whether the RDF mediates the formation of this loop.  
The other method by which BXBInt can mediate excision is by orientating AttB 
and AttP into the same molecule of DNA with a certain orientation with respect to each 
other. AttB and AttP are non-palindromic sequences, with a distinct orientation based on 
their core 8-nucleotide sequence. Like many members of the LSTR recombinases, 
when BXBInt AttB and AttP sites are in a “parallel” orientation with respect to each other 
on one molecule of DNA, BXBInt mediated recombination will occur between them, 
resolving in excision of the intervening DNA.52 This excision, like RDF mediated 
excision, requires the DNA between Att sites to form a loop in order for the Att sites to 
come into contact with BXBInt and for recombination to occur. This form of excision is 
unidirectional and will result in two molecules of DNA, the original molecule bearing 
either AttR or AttL, and a circular excision fragment bearing the other post- 
recombination site. This excision activity of BXBInt was first tested in the fission yeast 
Schizosaccharomyces pombe using both plasmid based and chromosomally integrated 
AttP/AttB substrates, and this activity was found to be somewhat less efficient using 
chromosomal substrates, although other LSTR family members were much more 







 The third mechanism of SSR is Inversion, or “flipping” of DNA. DNA inversion is 
observed in nature as exemplified by the Hin recombinase protein of Salmonella 
 
Figure 1-5: Excision mediated by BXBInt. The integrase enzyme binds to the attachment sites AttB and 
AttP, stabilizing the formation of a loop in the DNA. This protein/DNA complex is known as an 
invertosome. Once the invertosome is formed, strand exchange is mediated by the recombination. 
When the Att sites are in the parallel orientation (as shown by black and grey arrows), the result will be 
the excision of DNA between the two attachment sites. 
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enterica. Hin recombinase functions to invert a ~900 bp region of the Salmonella 
chromosome which acts as a promoter to either one or two ORFs responsible for 
flagellar protein synthesis.53 The mechanism of the Hin recombinase is thought to be 
representative of the mechanism of many serine recombinases: Hin-mediated DNA 
inversion involves a tetramer of the Hin protein, two dimers of an enhancer protein Fis, 
and a DNA-bending protein HU. These proteins work in concert to form a “loop” in the 
DNA strand known as an invertosome prior to catalyzing inversion54. The formation of 
the invertosome complex is thought to be similar to the mechanism of inversion 
catalyzed by other serine recombinases.    
The mechanism for BXBInt mediated inversion is similar to that of non-RDF 
mediated excision.  Excision and inversion activities for BXBInt are distinct from each 
other in the orientation of the AttB and AttP sites. Where excision occurs when AttB and 
AttP are in a “parallel” orientation with respect to each other on the same molecule of 
DNA, inversion occurs where the two sites are in an “antiparallel” orientation with 
respect to each other on the same molecule of DNA as shown in Figures 1.5 and 1.6:  
 
Otherwise, the mechanism of BXB1Int inversion is similar to that of LSTR 
excision, where DNA forms an invertosome complex, bringing AttP and AttB into 
proximity of BXBInt which facilitates strand exchange between the two sites.  This 
inversion results in a DNA sequence that has been inverted, and the two attachment 
sites resolve into distinct post-recombination sequences known as AttR and AttL.48 
Much like inversion and excision, this activity of BXBInt is highly directional, and may be 





Figure 1-6: Inversion of DNA mediated by BXBInt. Much like the process of excision, the integrase 
binds to the two Att sites to form an invertosome. When the Att sites are in the antiparallel orientation, 
the result of strand exchange in the invertosome will be inversion of the DNA between the Att sites. 
 
The inversion activity of LSTRs such as BXBInt has been a focus of interest for 
synthetic biologists.30,31,55 This interest is due in part to the fact that inversion does not 
commonly occur with the more commonly used tyrosine recombinases, although site-
directed mutagenesis of the Cre recombinase LoxP sites has been undertaken to 
26 
 
generate a small number of LoxP variants that favour inversion in mice.56  In contrast to 
the tyrosine recombinases, over 80 LSTRs have been identified, many of which are 
known or suspected to catalyze inversion in addition to integration and excision. The 
demonstrated ability of these enzymes to catalyze DNA inversion in vivo, the 
orthogonality of attachment site binding of LSTRs, as well as the large number of 
characterized enzymes, leads to the possibility of performing multiple separate DNA 
inversion events in living cells.  
  
1.3: THESIS OBJECTIVE 
The main impetus of this thesis is to develop the use of serine integrases in yeast 
to catalyze recombination. These enzymes have a number of properties that may be 
well suited for novel methods of synthetic gene expression. Currently, there are no 
characterized systems for differential and orthogonal regulation of multiple transgenes 
in S. cerevisiae. Induction systems that exhibit these properties would be valuable tools 
for the discipline of metabolic engineering that frequently makes use of simultaneous up 
and downregulation of native and heterologous genes in order to divert carbon flux. The 
serine integrase/Att site system of re-orienting a coding sequence with respect to a 
promoter element would have both of these properties, as the ability to activate 
expression of a gene or de-activate expression of a gene depends only on the starting 
state of the coding sequence, and ideally should be unbiased with respect to the DNA 




 The work presented in this thesis is an attempt to create a system of gene 
expression control using the inversion property of the serine integrase from BXB1, 
referred to as BXBInt or BXB integrase. The experiments presented will attempt to 
determine the parameters under which this enzyme is able to catalyze inversion in S. 
cerevisiae. Firstly, the effects of interpolating the BXBInt Att sites between the ORF of a 
yeast enhanced green fluorescent protein (yeGFP) ORF and the promoter and 
terminator of an expression cassette were quantified. To determine what conditions 
inversion occurs, three types of inversion targets were constructed in order to test the 
capabilities of BXBInt to catalyze recombination in situations, which may be applicable 
to other gene manipulation experiments. The first is the case of a plasmid-borne yeGFP 
ORF, which has been cloned in a reverse-compliment orientation with respect to a 
promoter and flanked by the BXBInt attachment sites AttB and AttP. This yeGFP ORF 
will rely on BXBInt to invert the ORF and bring it into an orientation that will allow for the 
correct transcription of the ORF. Successful inversion of the plasmid based reporter 
construct will be assayed by the expression of yeGFP only when BXBInt is expressed. 
Another construct to assay for BXBInt activity is composed of a plasmid borne yeGFP 
ORF cloned in the transcriptionally permissive “forward” orientation with respect to a 
promoter and flanked by BXB AttB and AttP.  In this case, expression of BXBInt can be 
used to turn off yeGFP expression. The third inversion target will be integrated into a 
yeast chromosome rather than being localized on a plasmid. The testing for inversion 
activity of these variants of the typical BXBInt substrate will provide evidence for or 




CHAPTER 2: MATERIALS AND METHODS 
2.1: LIST OF PLASMIDS, OLIGONUCLEOTIDES, AND STRAINS 
 
Table 2.1: List of plasmids 
Plasmid Genotype Description Source 
pGC966 
CEN6/ARS4ori, pMB1ori, 




CEN plasmid with LEU2 marker, protein 
expression under control of GAL1 
promoter, with deleted KpnI site and 506 





URA3, AmpR, loxP-KanR, 
PGAL1-HISstuffer-TCYC1 , 
ΔKpnI(3593-3598)A(3596)G 
CEN plasmid with URA3 marker, protein 
expression under control of GAL1 
promoter, with deleted KpnI site and 506 
homology cloning linkers. 
57 
pTDH3YEGFP 
pGC966 with forward-sense 
yeast-enhanced Green 
Fluorescent Protein 
Yeast Enhanced Green Fluorescent 
Protein (yeGFP) regulated by the strong 
constitutive promoter TDH3 
This thesis 
pYEGFPATTBP 
pGC966 with forward-sense 
yeast-enhanced Green 
Fluorescent Protein and 
BXB1 Int Att B and AttP sites 
yeGFP with the BXBInt AttB site interposed 
between the TDH3 promoter and the 
yeGFP ORF, and the AttP site interposed 




pGC966 with forward-sense 
yeast-enhanced Green 
Fluorescent Protein and 
BXB1 Int Att R and Att L 
sites 
Identical to pYEGFPATTBP, but with the 
BXBInt post-recombination sites AttR and 




pGC966 with reverse 
compliment-sense yeast-
enhanced Green 
Fluorescent Protein and 
BXB1 Int Att B and AttP sites 
Identical to pYEGFPATTBP, but with the 
yeGFP ORF cloned in the reverse 
compliment orientation with respect to the 
promoter 
This Thesis 
pBXBHA pGC967; GAL1p; BXBInt:HA 
pGC967 harbouring the integrase from 
BXB1 under the power of the galactose-
inducible GAL1 promoter, with an N-





pGC967 harbouring the integrase from 
BXB1 under the power of the galactose-
inducible GAL1 promoter, with an N-





pGC967 harbouring the integrase from 
BXB1 under the power of the galactose-
inducible GAL1 promoter, with an N-
terminal SV40 NLS tag 
This Thesis 
    
    
 


















TDH3YEGFP CEN.PK113-16B harbouring pTDH3YEGFP 
This thesis 
YEGFPATTBP CEN.PK113-16B harbouring pYEGFPATTBP 
This thesis 
YEGFPATTRL CEN.PK113-16B harbouring pYEGFPATTRL 
This thesis 
RCGFPATTBP CEN.PK113-16B harbouring pRCGFPATTBP 
This thesis 
BXBHA CEN.PK113-13D harbouring pBXBHA 
This thesis 
BXBTY1 CEN.PK113-13D harbouring pBXBTY1 
This thesis 
BXBSV40 CEN.PK113-13D harbouring pBXBSV40 
This thesis 
BXBHA_ RCGFPATTBP 
















CEN.PK113-13D with  the yeGFP expression 
cassette from pTDH3YEGFP integrated into 
Flagfedt site 16 
This thesis 
F16RCGFPATTBP 
CEN.PK113-13D with the Att site regulated reverse 
compliment yeGFP cassette from pTDH3YEGFP 
integrated into Flagfeldt site 16. 
This thesis 
F16RCGFPATTBP_BXBHA 
CEN.PK113-13D with the Att site regulated reverse 
compliment yeGFP cassette from pTDH3YEGFP 








Table 2.3: Oligonucleotides used in this thesis 
Number Oligo Name Primer Sequence 5’ to 3’   
pTDH3ATTBP construction  
  
1.  MLT 506 TDH3 F taaccctcactaaagggaacaaaagctggagctcgtttaaacggcgcgcctcgagtttatcattatcaatactgcc  
2.  MLT TDH3 R ctctagcgaagagcactagttctagagg  
3.  MLT ENO2T F blunt agtgcttttaactaagaattattagtcttttctg  














7.  MLT tdh3_ATTB F tcttttttttagttttaaaacaccaagaacttagtttcgaggccggcttgtcacgac  
8.  MLT attp_YEGFP_R gggtttgtaccgtacaccactgagaccgcggtggttgaccagacaaaccactaattatttgtacaattcatccataccatg  




10.  MLT eno2t_ATTP R gatgaaaaaataagcagaaaagactaataattcttagttaaaagcacttgggtttgtaccgtacacc  
11.  MLT TDH3 attB R  ccggatgatcctgacgacggagaccgccgtcgtgacaagccggcctcgaaactaagttcttggtg  
 
pYEGFPATTRL construction  
  
12.  






MLT yeGFP Forward 
attRL R 
tgggtttgtaccgtacaccactgagatctccgtcgtcaggatcatccggatgttatttgtacaattcatccataccatg  
14.  MLT eno2t_ATTL_R aaaataagcagaaaagactaataattcttagttaaaagcacttgggtttgtaccgtacacc  
15.  MLT tdh3_ATTR_F tttagttttaaaacaccaagaacttagtttcgaggccggcttgtcacgac  
 











pBXBHA and BXBInt expression cassette construction  
  
18.  MLT BxB1 Integ F tcggtaatgggatccctctagaactagtgctcttcgctagagatgagagccctggtagtcatc  
19.  MLT BxB1 Integ R gctcactttaatttcggtttcgttatcttccaggctgcgttttttctacgacatcccggtgtgtag  
20.  MLT TDH2t F atttaactccttaagttactttaatgatttag  
21.  MLT TDH2t R gcgaaaagccaattagtgtg  
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22.  MLT TDH2t 506 ataacttcgtataatgtatgctatacgaagttattaggtaccgcgaaaagccaattagtgtg  
23.  




MLT Gal1p R No 
Linker 
atccggggttttttctccttg  
25.  MLT 506 Gal1p F taaccctcactaaagggaacaaaagctggagctcgtttaaacggcgcgccgtttaaacggcgcgcctag  
26.  MLT Gal1p bxb R catcggtgacgcgggacaggcggatgactaccagggctctcatatccggggttttttctcc  
27.  








MLT BXB1 int :: TY1L 
R 
ttaatttcggtttcattgtcctctagggatcttttttttgaatttattgtagtcgacatcccggtgtgtagc  













Integration construct assembly 
 
33.  







LN_univ_int_f_16u3p_tail tagacaaacgaagtgattgaaacccgaattaacggagcaggttaacctggcttatcgaa  
36.  
LN_univ_int_R_c1_tail ctcaaagtaatgctgcagtctcggcgcgccggctacaattaatacataaccttatgtatc  
37. * 
LN_16d5p_F_C6_tail ggcaatcacatcaccatgagttgtgcggccgctgcctacgcaacactttagctg  
38. * 












2.2: POLYMERASE CHAIN REACTION OF REPORTER CONSTRUCT CASSETTES 
 
 In order to gauge the activity of BXBInt in S. cerevisiae, a two-plasmid strategy 
was applied. One plasmid expressed yeGFP,58 which has been codon-optimized for 
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expression in S. cerevisiae  and the other plasmid expressed the BXBInt enzyme. In 
order to create a valid fluorescent assay, plasmids were constructed via a DNA 
Assembler59 based strategy as illustrated in Figure 2-1. 
 
 
Figure 2-1: Schematic representation of DNA Assembler based cloning strategy. A: Insert fragments 
are amplified from numerous sources using primers synthesized such that they incorporate 40 bp 
sequences homologous to each adjacent amplicon and to the vector. B: the pGC966 and pGC967 
vectors used in this study were prepared by digestion with AscI and KpnI which will expose 50 bp 
sequences compatible with homology-based cloning. C: Amplicons and linearized plasmids are co-
transformed into a CEN.PK strain of yeast via lithium acetate/ssDNA mediated heatshock, and the 
Homologous Recombination pathway of the yeast assembles the amplicons and linearized backbone 
into a closed, circularized plasmid. 
 
  To construct the pTDH3YEGFP yeGFP expression cassette, promoter and 
terminator sequences were amplified using CEN.PK genomic DNA as a template, using 
primers 1 and 2 for the TDH3 promoter and primers 3 and 4 for the ENO2 terminator. 
These primer sets were designed to incorporate the ~40 bp 506 region of homology to 
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the vector. The vectors used in this study are based on the pGreg vector system,60 
modified to create unique KpnI and AscI restriction endonuclease sites to facilitate DNA 
Assembler cloning.57 The yeGFP sequence was amplified by PCR using pGC966 as a 
template, and using primers 5 and 6, which would add 40 bp of homology to the 
promoter and terminator amplicons.  
The cassette of interest for pYEGFPATTBP was constructed by amplifying the 
TDH3 promoter and ENO2 terminator from CEN.PK genomic DNA using 1 and 2 for the 
TDH3 promoter and primers 3 and 4 for the ENO2 terminator. The TDH3 amplicon was 
used as a template for primers 1 and 11, which would incorporate the sequence for AttB 
to the 3’ end of the promoter sequence. The ENO2 amplicon was used as a template for 
primers 4 and 10, which would add the sequence for AttP to the 5’ end of the terminator 
sequence. The yeGFP sequence was amplified using pGC966 as a template and 
primers 8 and 9, which would add the AttP and AttB sequences to the forward-
orientation yeGFP amplicon.   
The cassette of interest for pYEGFPATTRL was constructed by amplifying the 
yeGFP ORF from pGC966 using primers 12 and 13, which add the sequences for AttR 
and AttL to the 5’ and 3’ ends of the yeGFP amplicon. This amplicon was used as a 
template for a PCR reaction, which would add 40 bp of homology to the TDH3 promoter 
and ENO2 terminator using primers 34 and 35. Promoter and terminator sequences 
were amplified from CEN.PK genomic DNA using primers 1 and 2 for the TDH3 
promoter and primers 3 and 4 for the ENO2 terminator. 
The cassette of interest for pRCGFPATTBP was constructed by amplifying the 
yeGFP ORF using pGC966 as a template, and using primers 16 and 17 to amplify the 
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yeGFP ORF in the reverse compliment orientation with respect to the AttB and AttP 
sequences included in the primer sequences. This amplicon was used as a template in 
a further amplification to add 40 bp of homology to the TDH3 promoter and ENO2 
terminator using primers 10 and 11. Promoter and terminator sequences were amplified 
using CEN.PK genomic DNA as a template, using primers 1 and 2 for the TDH3 
promoter and primers 3 and 4 for the ENO2 terminator, which will amplify these 
regulatory elements with 40 bp linkers homologous to the 506 regions of pGC966. 
Schematic representations of the cassettes of interest from the aforementioned 
plasmids showing the location and orientation of regulatory elements with respect to the 





Thermal cycling conditions for all reactions were optimized for the Phusion DNA 
Polymerase (New England Biolabs, Ipswich, MA, USA), with denaturing and annealing 
temperatures optimized for each template and primer set. PCR amplicons were 
subjected to electrophoresis in 0.8% (w/v) agarose gel with Tris/Acetate/EDTA (TAE) 
buffer. Amplicons of the correct size were excised from the gel and purified using the 




Figure 2-2: Schematic representations of the four constructs assembled to validate the activity of 
BXBInt in S. cerevisiae. A: Cassette from pTDH3YEGFP. B: Cassette from pYEGFPATTRL. C: 




All plasmids were assembled via Transformation Associated Recombination 
(TAR) mediated by the Lithium Acetate/PEG/ssDNA method.61 The pGC966 and 
pGC967 vectors used in this portion of the study differ from the original pGREG vectors 
from whence they derive in that they included two 50-bp sequences which are the sites 
of homologous recombination during TAR assembly, referred to as the “506” linkers of 
the vector in Fossati et al..57.  The 506 linker sequences were exposed by digesting the 
vectors with AscI and KpnI (purchased from New England Biolabs, Ipswich, MA, USA). 
This digest was subjected to electrophoresis in 0.8% (w/v) agarose gel with TAE buffer. 
Linearized vector backbone was excised from the gel and purified using the 
ThermoFisher GeneJET Gel Extraction kit (ThermoFisher Scientific, Waltham, MA, 
USA). 
 Between 100 and 500 femtomoles of linearized vector and 300-1000 femtomoles 
of PCR products were pooled and introduced into yeast cells via lithium acetate 
mediated heat shock as described by Gietz & Schiestl.61 
 Reporter construct plasmids were used to transform CEN.PK auxotroph strains 
deficient in either the LEU2 or URA3 markers, such that successful recombination 
would complement these auxotrophies and allow for selection of assembled constructs 
by growth of the transformants on minimal media.  A 1/5 and 1/50 dilution of each 
transformation reaction were plated YNB + 2% (w/v) glucose agar plates. In parallel, 
each CEN.PK strain was also transformed with only the linearized pGC966 vector as a 
negative control. Transformation plates were incubated at 30°C for 48-72 hrs, or until 
colonies became visible. Transformation reactions where a significantly greater (at least 
tenfold) number of colonies appeared on the transformation plates compared to the 
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negative control plates, putative transformant colonies were used to inoculate 5 mL 
cultures of liquid YNB + 2% (w/v) glucose in glass test tubes and incubated at 30°C with 
shaking at 200 RPM overnight.  
Putative assembled vectors were purified from yeast cells by centrifuging 1-mL of 
overnight cultures at 16,000 RCF, decanting media, and suspending cell pellets with 50 
µL of yeast lytic enzyme Zymolase 20-T (Amsbio, Cambridge, MA, USA product no. 
120491-1) solution containing 50 uL of 100% β-mercaptoethanol per mL of lytic enzyme 
solution. Cell pellets suspended in lytic enzyme solution were incubated for 2-3 hrs at 
37°C and plasmids purified using a Thermo Scientific GeneJet plasmid extraction kit 
modified for yeast plasmid purification by doubling the volume of reagents used in the 
protocol compared to bacterial plasmid purification.  
 Purified plasmids were used to transform E. coli strain DH5α via CaCl2 mediated 
heat shock, and isolated colonies were grown in Luria Bertani liquid media with 100 
μg/mL of ampicillin overnight and stored in 15% (v/v) glycerol at -80. Plasmids purified 
from E. coli stocks were sequenced by Eurofins Operon Genomics (Huntsville, AL, 
USA). 
 
2.3: ASSEMBLY OF BXBINT PLASMIDS 
 The BXBInt expression cassettes were constructed by amplifying the BXBInt 
ORF using the International Genetically Engineered Machines (iGEM) 2011 distribution 
part BBa_I20284, whose sequence was obtained from47 and can be found at 
(http://parts.igem.org/Part:BBa_I20284: Design as of February 2016). Primers 18 and 
19 were used to amplify the ORF of BXBInt. This amplicon was used as a template for 
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further amplification to add the C-terminal tags to the BXBInt ORF and homologous 
sequences to terminator amplicons. Primers 27 and 28 were used to create the HA-
tagged variant with homology to the TDH2 terminator, primers 27 and 31 were used to 
create the SV40NLS tagged variant, and primers 27 and 29 were used to create the 
Ty1NLS tagged variant. Primer 27 included the consensus Kozak sequence (5’-
aaaaaaatgagat-3’) which would be incorporated immediately upstream of the BXBInt 
ORF. The sequence of primer 28 included a yeast codon-optimized DNA template for 
the HA tag amino acid sequence (YPYDVPDYA). The sequence of the Ty1 NLS 
included in primer 29 was a yeast codon optimized DNA template for the amino acid 
sequence (TTINSKKRSLEDNETEIKVSRDTW) as described in Moore et al.62 The 
SV40NLS sequence included in primer 31 was a yeast codon-optimized DNA template 
for the amino acid sequence (PKKKRKV) as described in Makkerh et al.63 The GAL1 
promoter was amplified using pGC966 as a template and using primers 23 and 24. This 
amplicon was used as a template for primers 25 and 26 to amplify the GAL1 promoter 
with the 506 linker and 40 base pairs of homology to the BXBInt ORF. The TDH2 
terminator was amplified using CEN.PK genomic DNA as a template and using primers 
20 and 21. This amplicon was used as a template for further amplification to add linker 
sequences to the TDH2 terminator amplicon. Primers 20 and 22 were used to add the 
linker sequence homologous to the 506 vector linker to the 3’ end of the terminator 
sequence. Primers 32 and 22 were designed to add the 506 linker and the SV40NLS 
sequence, Primers 30 and 22 were used to add 506 linker homology and Ty1 NLS 
sequence to the terminator amplicon. 
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2.4: QUANTIFICATION OF GFP FLUORESCENCE FROM TDH3YEGFP, 
YEGFPATTBP, AND YEGFPATTRL 
 
The chosen structure of the BXBInt-mediated inversion cassette was designed to 
place AttB between the strong constitutive promoter TDH3 and the yeGFP ORF, and to 
place AttP between the yeGFP ORF and the ENO2 terminator. It was considered likely 
that this construct design may impact expression of the yeGFP reporter. To quantify 
what that effect may be, plasmids pTDH3YEGFP, which consisted of the forward 
orientation yeGFP under the power of TDH3 without Att sites, was constructed to serve 
as a baseline for expression. pYEGFPATTBP and pYEGFPRL were constructed to 
contain a cassette where the pre-recombination AttB and AttP sites were interpolated 
between the ORF and regulatory elements and the post-recombination AttR and AttL 
sites in those same places, respectively. yeGFP fluorescence was quantified by flow 
cytometry.  
Strains TDH3YEGFP, YEGFPATTBP, and YEGFPATTRL, were created via 
lithium acetate/PEG/ssDNA transformation by their respective plasmids (Table 2.1 and 
2.2) and transformants selected on YNB + 2% (w/v) glucose agar plates. Three colonies 
from each plate were used to inoculate 5 mL of YNB + 2% (w/v) glucose in 25mm x 
150mm borosilicate test tubes and all cultures were incubated at 30°C with shaking at 
200 RPM on a rotary shaker for 18 hrs. Overnight cultures were diluted 1:10 in fresh 
media in preparation for flow cytometry. 
Cells were analyzed by flow cytometry using an Accuri C6 cell analyzer from BD 
Biosciences (San Jose, CA, USA). This analyzer was equipped with a λ 488nm 
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excitation laser and λ 530/30 emission filter optimized for GFP fluorescence. A second 
detection filter channel at λ585/40 was also used to get a 2-dimensional map of green 
fluorescence and red autofluorescence.  Gating of the cell analyzer data to get 
consistent measurements of only yeast cells in a similar stage of the cell cycle was as 
follows: Raw input from the detectors was normalized for Side Scatter Height (SSC-H) 
and Forward Scatter Height (FSC-H) to control for cell size. Events were gated along 
the line where a 1:1 SSC-Area: SSC-H ratio would be to ensure that only fluorescence 
from single cells is measured. The fluorescence from events, which were located within 
this gate was used to determine GFP fluorescence. GFP fluorescence was measured 
using the FL1 channel, corresponding to λ530/30 filtered detector. Measures of green 
fluorescence reported were the mean fluorescence from the FL1 channel, the 
percentage of events in the UL quadrant, and the mean fluorescence of events in the 
UR quadrant. Another graph of events was constructed consisting of a simple histogram 
of fluorescence from events from the FL1 channel, which could be gated around a non-
fluorescent empty vector control. Mean fluorescence and the percentage of events 
whose FL1 values exceeded the gated value were recorded. Mean fluorescence values 
are reported in Chapter 3.1. 
 
2.5: TESTING THE FUNCTION OF BXBINT IN S. CEREVISIAE VIA FLOW 
CYTOMETRY 
 
 The function of BXBInt to catalyze inversion of plasmid DNA in S. cerevisiae was 
assayed by generating the plasmids pBXBHA, pBXBTy1, and pBXBSV40, all of which 
contained the BXBInt ORF under the power of the galactose inducible reporter GAL1. 
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These plasmids were co-transformed alongside pRCGFPATTBP and pYEGFPATTBP, 
consisting of the reverse compliment sense yeGFP ORF and forward sense yeGFP 
ORF respectively, both flanked by AttB and AttP. Once BXBInt was expressed by 
growing the strains generated by this transformation in media containing galactose, 
inversion of the DNA on the yeGFP bearing plasmids could be inferred by flow 
cytometry looking for the appearance or disappearance of GFP fluorescence. 
Strains RCGFPATTBP, BXBHA_YEGFPATTBP, BXBHA_ RCGFPATTBP, 
BXBTY1_ RCGFPATTBP, and BXBSV40_ RCGFPATTBP were created via lithium 
acetate/PEG/ssDNA transformation by their respective plasmids (Table 2.1) and 
transformants selected on YNB + 2% (w/v) glucose agar plates. For galactose-induction 
experiments, six colonies from each transformation plate were picked and used to 
inoculate 5-mL cultures of YNB media for overnight growth. Three colonies from each 
plate were used to inoculate YNB + 2% (w/v) glucose and three colonies were used to 
inoculate YNB + 2% (w/v) galactose, and all cultures were incubated at 30°C with 
shaking at 200 RPM on a rotary shaker for 18 hrs. Overnight cultures were diluted 1:10 
in fresh media in preparation for flow cytometry. Flow cytometry was carried out as 
described in Section 2.4. 
  
2.6: TIME COURSE 
 To determine the timing and heritability of BXBInt inversion, as well as to account 
for the relatively high stability of yeGFP in yeast cells when attempting to invert the 
pYEGFPATTBP yeGFP cassette, long-term incubation of strains RCGFPATTBP, 
BXBHA_RCGFPATTBP, and BXBHA_YEGFPATTBP in liquid culture was carried out. 
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For this experiment, strains RCGFPATTBP, BXBHA_RCGFPATTBP, and 
BXBHA_YEGFPATTBP were grown overnight in YNB + 2% (w/v) glucose in 25mm X 
150mm test tubes with shaking at 200 RPM for 18 hrs. After the cultures had grown to 
significant density, cells were washed with sterile ddH2O, and used to inoculate 5 mL of 
induction medium composed of YNB + 2% (w/v) galactose. In parallel, these cultures 
were used to inoculate fresh YNB + 2% (w/v) glucose as negative controls. Cultures 
were incubated as stated above for 72 hrs. Subsamples of each culture (100 μL) were 
analyzed by flow cytometry as described in Section 2.4 after being transferred to the 
induction medium. After 72 hrs of growth, those cultures grown in galactose were diluted 
1/5000 in fresh media composed of YNB + 2% (w/v) glucose and analyzed by flow 
cytometry. Results are shown in Sections 3.2 and 3.3.  
 
2.6: INTEGRATION OF THE REPORTER CONSTRUCT INTO YEAST 
CHROMOSOME14 
 In addition to constructing plasmids bearing the yeGFP reporter constructs, 
attempts were made to integrate these same reporter constructs into the genome of S. 
cerevisiae in order to determine whether BXBInt could invert genomic DNA. The site of 
the integration event was selected based on a study by Flagfeldt et al.,64 wherein 
multiple genomic integration sites were characterized based on the level of gene 
expression of an integrated reporter cassette. Flagfeldt site 16 was selected based on 
the high expression levels of integrated reporter constructs found in this study, and 
based on the high quality of publicly available sequence information of this region of the 
yeast genome. Site 16 is located on the p arm of chromosome 14, at the YNRCΔ9 locus 
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(SGD ID S000007145), an intergenic Long Terminal Repeat (LTR) sequence from the 
Ty1 retrotransposon.65 Integration of the reporter constructs from pTDH3YEGFP and 
pRCGFPATTBP was attempted by simple homologous recombination of a linear DNA 
construct of the reporter construct linked to a G418 resistance cassette and two ~600 
bp regions of chromosomal homology upstream and downstream of the YNRCΔ9 LTR. 






Figure 2-3: Schematic representation of the strategy implemented to integrate the RCGFPATTBP 
construct into Flagfeldt Site 16. The integration cassette was amplified in four parts, which were spliced 
together by SOE-PCR. Upon transformation of CEN.PK113-13D, the integration cassette was expected 
to recombine into Flagfeldt site 16. Integration carried out in this manner could be selected for using 
G418. 
 
The Site 16 Upstream (16U) chromosomal homology regions were amplified from 
CEN.PK genomic DNA with primers 33 and 34, which incorporated 40 base pairs of 
homology to both a G418 resistance cassette derived from the pUG6 plasmid. This 
G418 resistance cassette was amplified using pUG6 as a template and primers 35 and 
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36. Primer 36 incorporated a 40 bp linker sequence, called C1, which would facilitate 
homologous recombination or Splicing by Overlap Extension PCR (SOE-PCR) with the 
downstream amplicon. The TDH3YEGFP and RCGFPATTBP cassettes amplified using 
plasmids pTDH3YEGFP and pRCGFPATTBP as templates and using primers 39 and 40 
in both cases. These primers would incorporate the C1 linker to the 5’ terminus of the 
amplicon and the similarly designed 40 bp C6 linker sequence to the3’ end of this 
amplicon. The Site 16 Downstream chromosomal homology region (16D) sequence was 
amplified using primers 37 and 38, which would add the C6 linker to the 5’ terminus of 
the amplicon. The two chromosomal homology regions, the G418 cassette, and reporter 
construct cassette were amplified into one fragment of DNA by SOE-PCR using a mix of 
the four amplicons described above (diluted 1/10, approximately 10 ng of each 
amplicon) as template and primers 33 and 38. Thermal cycling conditions were 
optimized for the Phusion polymerase (New England Biolabs, Ipswich MA, USA). The 
spliced PCR product was subjected to electrophoresis in 0.8% (w/v) agarose gel with 
TAE buffer. Amplicons of the correct size were excised from the gel and purified using 
the ThermoFisher GeneJET Gel Extraction kit (ThermoFisher Scientific, Waltham, MA, 
USA) and used to transform strains of CEN.PK113-13D via the lithium 
acetate/PEG/ssDNA method. Transformants were plated on YPD + G418 agar plates 
and incubated at 30°C for three days. A negative control transformation containing only 
the Site 16 homology amplicons and the G418 resistance cassette was undertaken in 
parallel. In order to ensure that individual clones were isolated, colonies from the 
transformation reaction were picked and re-streaked on fresh YPD + G418 plates and 
incubated in an identical manner. Colonies from the first round re-streak plates were 
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also picked and re-streaked on fresh YPD + G418 plates and incubated a second time. 
Colonies from the second round re-streak plates were selected for further analysis.  
 Successful integration of reporter construct cassettes was verified by PCR. 
Genomic DNA was extracted from cells by growing putative integrants overnight in YPD 
+ G418 liquid cultures, centrifuging 1 mL of cultures, which grew in the selective media 
to obtain cell pellets. Cells were lysed by suspending the cell pellets in 50 μL of a 
solution composed 0.3 mM lithium acetate and 20% (v/v) dimethyl sulfoxide in ddH2O. 
Four volumes of 95% (v/v) ice-cold ethanol was added to the lysate, the solution was 
mixed thoroughly, and incubated at -20°C for 30 minutes in order to precipitate DNA. 
Samples were centrifuged at 16,000 RCF for 20 minutes at 4°C to pellet DNA, after 
which the supernatant was decanted and the DNA pellet washed with ice-cold 70% (v/v) 
ethanol. DNA pellets were dried and suspended in ddH2O. One microliter of this DNA 
extraction was used as a template in a 50 μL PCR analysis using four primer sets: 





Figure 2-4: PCR reactions used to map the integration cassette from purified genomic DNA of G418 resistant colonies. Primers 
used are shown based on their numbers in Table 2-3.  A: Primers 33 and 38 in the background strain CEN.PK113-13D would 
amplify a short, ~500bp fragment. B: Primers 33 and 38 would amplify a large ~5 kb fragment if integration was successful. C: 
primers 35 and 36 would amplify a 2 kb fragment. D: primers 39 and 40 would amplify a 2 kb fragment. E: Primers 39 and 38 
would amplify a ~2.5 kb fragment. 
 
 Colonies that tested positive for features of the pRCGFPATTBP integration 
cassette were then transformed with the pBXBHA plasmid to test for inversion activity of 
chromosomally integrated DNA. Plasmid was transformed using the lithium 





2.7: FLUOROMETRY OF PUTATIVE RCGFPATTBP INTEGRANTS 
 F16TDH3YEGFP, F16RCGFPATTBP, and F16RCGFPATTBP_BXBHA strains, 
which were transformed with the galactose inducible BXBInt plasmid pBXBHA were 
analyzed by microtiter plate fluorometry. Transformants were grown for 24 hrs in YNB + 
2% (w/v) glucose (control) and YNB + 2% (w/v) galactose, to induce expression of 
BXBInt. Cultures were diluted in ddH2O to an OD660 of 1. Fluorescence analysis of 
F16TDH3YEGFP, F16RCGFPATTBP, and F16RCGFPATTBP_BXBHA strains was 
carried out using a Tecan Infinite 200 plate reader instrument. Cultures were transferred 
to BD Falcon 96 well flat bottom transparent/black polyethylene terephthalate HTS 
FluoroBlok plates in aliquots of 100 μL. Fluorometric parameters were as follows: 
Excitation wavelength of 475/9, emission wavelength detected at 509/20, gain set to 
100, 25 flashes per well. Plates were set to shake for 1 second with a linear amplitude 
of 1 mm at 100 RPM before each measurement. Biological triplicates of each strain 
were analyzed and average fluorescence was recorded, the results of which can be 
found in Section 3.4. 
CHAPTER 3: RESULTS 
 
3.1: EFFECT OF ATT SITES ON YEGFP EXPRESSION LEVELS 
 
Quantitative flow cytometry was undertaken to determine whether the presence 
of Att sites between promoter and the reporter ORF would impact expression of that 
reporter, which would be an important factor to consider if this system of gene 
expression control is to be used for quantitative biological manipulations. Figure 3-1 
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shows a comparison of yeGFP expression from a CEN.PK1113-16B strain bearing a 
pGC966 derivative with a non-protein coding DNA fragment as a negative control, 




Figure 3-1: Flow cytometry of TDH3YEGFP, YEGFPATTBP, and YEGFPATTRL. Bars represent 
average fluorescence of three biological replicates, black lines indicate standard error.  Interpolating 
the AttB and AttP sites between the ORF and promoter/terminator leads to a 100-fold decrease in 
fluorescence compared to the same construct without the Att sites, while interpolating the post-
recombination AttR and AttL in the same locations leads to a 10-fold decrease in fluorescence 
compared to TDH3YEGFP. Also shown is the fluorescence from CEN.PK113-16B transformed with a 
non-fluorescent empty pGC966 vector (EVC) 
 
 
The greatest amount of fluorescence comes from the construct without any Att 
sites separating the promoter region from the start codon of the yeGFP ORF. The 
construct where the AttB site is located between the promoter and coding sequence and 
the AttP site located between the end of the coding sequence and the terminator 




























control. The construct with the BXB AttR and AttL sites situated between the promoter, 
coding sequence, and terminator results in approximately 10% of the fluorescence of 
the non-Att site bearing control, ten times brighter than the AttB and AttP site bearing 
control.  
3.2: SERINE INTEGRASE MEDIATED INVERSION OF PLASMID DNA 
Figure 3-2 shows the results of flow cytometry of RCGFPATTBP, BXBHA, and 
BXBHA_RCGFPATTBP grown in minimal media containing glucose and galactose. 
 
 
Figure 3-2: Flow cytometry of BXBInt mediated inversion. Yeast strains bearing either the 
pRCGFPATTBP plasmid, the galactose-inducible pBXBHA g plasmid, or BXBHA_RCGFPHA 
harbouring both plasmids, were grown for 24 hrs either in YNB + 2% (w/v) glucose or YNB + 2% (w/v) 
galactose. Bars represent the mean fluorescence of three biological replicates, black lines represent 
the standard error three biological replicates. Fluorescence intensity is reported in arbitrary units (AU). 
Fluorescence intensity only increases above background levels when both pBXBHA and 
pRCGFPATTBP are present in the cell, and BXBInt expression is induced with galactose, indicating 



























YeGFP expression was not observed in the presence of the reporter construct 
alone, ruling out the possibility that the pRCGFPATTBP cassette could be induced by 
galactose on its own. The absence of fluorescence from the pRCGFPATTBP plasmid 
transformed strain also indicates that yeGFP is not expressed prior to the expression of 
BXBInt. The lack of fluorescence from strain BXBHA precludes any contribution of the 
BXBInt plasmid or protein to fluorescence. Fluorescence is only observed in the strain 
harbouring both pRCGFPATTBP and pBXBHA when grown in galactose. These results 
make sense in light of the DNA inversion hypothesis, where induction of the BXBInt 
protein remodels the reporter construct such that the yeGFP ORF is in an orientation 
with respect to the TDH3 promoter that permits translation and transcription of a 
functional yeGFP transcript and protein. This result provides strong evidence of the 
inversion activity of a serine integrase in yeast.  
 In order to determine the timing of serine integrase mediated inversion, the 
expression of yeGFP was measured over a 24 hrs post-galactose induction period 
(Figure 3-3). This experiment shows that yeGFP fluorescence becomes detectable by 








Figure 3-3: Time course of BXBInt inversion. Yeast strains are BXBHA (circles), RCGFPATTBP plasmid 
(diamonds) and BXBHA_RCGFPATTBP (squares). Expression of the inverted yeGFP reporter peaks at 5 
hrs and slightly decreases after 24 hrs. Points represent average ungated fluorescence of three biological 






























Variants of the BXBInt protein bearing C-terminal nuclear localization sequences 
were constructed to determine whether nuclear localization would have an effect on 
GFP fluorescence. It is possible that when BXBInt is synthesized in the cytosol of the 
cell, the nucleus might act as a barrier preventing the integrase from accessing the 
plasmid bearing the reporter construct. Figure 3-4 shows fluorescence from strains 
BXBHA_RCGFPATTBP, BXBTY1_RCGFPATTBP, and BXBSV40_RCGFPATTBP. 
There is no difference in the average fluorescence of strains expressing the different C-
terminal tags, indicating that nuclear localization is not a significant obstacle towards 
BXBInt inversion of plasmid DNA. Figure 3-5 shows the fluorescence of strains 
BXBHA_RCGFPATTBP, RCGFPATTBP, and BXBHA grown for three days in induction 
 
Figure 3-4: Effectiveness of C-terminal tagged BXBInt variants. Flow cytometry of yeast strains bearing 
the pRCGFPATTBP plasmid, as galactose inducible BXBInt bearing vectors with different C-terminal 
tagged BXBInt variants. Categories represent average ungated fluorescence of three biological 


























media followed by 24 hrs in glucose. There is no significant decrease in fluorescence of 
BXBHA_RCGFPATTBP when grown in galactose for 24 hrs and 72 hrs, or when back 
diluted into glucose containing media. This indicates that the inversion of DNA mediated 





3.3: FYEGFPATTBP: TURNING OFF GENE EXPRESSION USING BXBINT 
The proposed mechanism of serine integrase mediated DNA inversion implies 
that the initial orientation of a DNA sequence flanked by Att sites should be irrelevant so 
 
Figure 3-5: Long-term expression of BXBInt mediated inversion. Bars show average fluorescence of 
three biological replicates and black lines show standard error. Cultures were grown in YNB + 2% (w/v) 
glucose and YNB + 2% (w/v) galactose for 72 hrs, after which they were backdiluted into fresh YNB + 






















Long-term fluorescence of BXBInt DNA inversion
Glucose 24 hrs Glucose 72 Hours
Glucose Backdiluted into Glucose Galactose 24 hrs
Galactose 72 Hours Galactose Backdiluted into Glucose
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long as the orientation of the Att sites favours recombination, and that DNA inversion 
should occur regardless of the initial state of the intervening DNA. To test this 
hypothesis about the BXBInt system an alternate reporter construct, YEGFPATTBP, 
was constructed consisting of the yeGFP ORF flanked by the BXB AttB and BXB AttP 
sites, cloned in the transcriptionally permissible “forward” orientation with respect to the 
TDH3 promoter and ENO2 terminator. Flow cytometry of yeast cells bearing this 
reporter construct plasmid shows that there is significant GFP fluorescence in the 
magnitude expected of a GFP ORF separated from the TDH3 promoter sequence by a 
DNA sequence as shown in Figure 3-6, further demonstrating that this reporter 




Figure 3-6: Fluorescence of YEGFPATTBP inversion. Flow cytometry of yeast cultures bearing 
pYEGFPATTBP, pBXBHA, and both plasmids plasmid after 24 hrs of growth in YNB + 2% (w/v) glucose 
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Co-transformation of the pYEGFPATTBP plasmid and the pBXBHA plasmid also 
proceeded as expected of a successful co-transformation. A uracil and leucine 
auxotrophic strain (CEN.PK 17A) subjected to lithium acetate mediated heat shock in 
the presence of both plasmids yielded viable colonies when plated on YNB + 2% (w/v) 
glucose agar plates, where the same double auxotrophic strain transformed with the 
pYEGFPATTBP plasmid alone yielded no viable colonies. Growing the viable colonies 
from the double transformation experiment in YNB + 2% (w/v) glucose and YNB + 2% 
(w/v) galactose yields an interesting result. After 24 hrs of logarithmic growth from a 
single colony to a high-density liquid culture, there is no difference in the GFP 
fluorescence of the yeast bearing both the YEGFPATTBP and BXBHA_YEGFPATTBP 
strains grown in glucose and grown in galactose. This pattern was also observed after 
72 hrs of growth, and also after back diluting the cultures into fresh induction media, as 
is shown in Figure 3-7. This back dilution was performed so as to allow for the yeast to 
divide for several generations in the induction media in order to eliminate any effect that 
the stability of the yeGFP protein would have on the observations. 
Figure 3-8 shows the percentage of flow cytometry events that show GFP 
fluorescence exceeding the level gated around a non-fluorescent empty vector control. 
This graph shows a similar pattern to that shown in Figure 3-7, where there is a 
decrease in fluorescence observed in those cells grown in galactose compared to 
glucose for both YEGFPATTBP and BXBHA_YEGFPATTBP over the course of 72 
hours. There appears to be no significant difference in GFP fluorescence over the 




Back dilution into fresh media does appear to reveal a difference in the proportion 
of GFP fluorescing cells between YEGFPATTBP and BXBHA_YEGFPATTBP. 
YEGFPATTBP grown in glucose for 72 hours and back diluted into glucose shows 
66.7% of cells fluoresce above the background, where YEGFPATTBP grown in 
galactose for 72 hours and back diluted into glucose shows 53.4% of cells fluoresce 
above the background level. BXBHA_YEGFPATTBP grown in glucose for 72 hours and 
back diluted into glucose shows 66.4% of cells fluoresce above the background, where 
BXBHA_YEGFPATTBP grown in galactose for 72 hours and back diluted into glucose 
shows 32.4% of cells fluoresce above the background level. Also shown is the 
percentage of BXBHA_RCGFPATTBP cells that fluoresce above background level 








Figure 3-7: Fluorescence of YEGFPATTBP after 24, 72, and 96 hrs of induction. Attempted inversion of 
pYEGFPATTBP monitored for fluorescence at 24 and 72 hrs post induction, and following re-




Figure 3-8: The proportion of cells whose green fluorescence exceeds the level of the gate set around 
an empty vector control. Fluorescence of YEGFPATTBP after 24, 72, and 96 hrs of induction. 
Attempted inversion of pYEGFPATTBP monitored for fluorescence at 24 and 72 hrs post induction, and 
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3.4: INTEGRATION OF REPORTER CONSTRUCT INTO CHROMOSOME 14 
  
Literature characterizing the activity of LSTRs in microbial hosts does not include  
published attempts to invert chromosomal DNA.52 To this end, the pRCGFPATTBP 
cassette was integrated into chromosome 14 at Flagfeldt site 16. An integration 
cassette was constructed in four parts to be assembled via TAR and integrated via 
homologous recombination. The four parts were a 627 bp upstream region of homology 
to Site 16 (Site 16 Up), a 1601 bp G418 resistance cassette from the pUG vector 
(G418r), the 1800 bp reporter construct cassette from the previously described 
pRCGFPATTBP or pTDH3YEGFP plasmids, and a 673 bp region of downstream 
homology to Flagfeldt site 16 (Site 16 Down). These parts were amplified using primers 
that added ~40 bp of overlap to their adjacent parts. When 500 ng of each part was 
used to transform the uracil auxotrophic strain CEN.PK 13D via lithium 
acetate/PEG/ssDNA mediated heat shock and plated on YPD + G418 agar plates, 
dozens of colonies appeared on plates inoculated with the yeast transformed with all 
four parts, and no colonies appeared on plates inoculated with yeast transformed with 
only the Site 16 Up, G418R parts, and Site 16 Down parts. Colonies from the 4-part 
transformation reaction were picked and streaked onto fresh YPD + G418 plates, 
resulting in successful growth of these colonies on fresh plates. Inoculating fresh YPD + 
G418 plates using a pipette tip which had been dragged across the surface of the plate 
which had been inoculated with the 3-part transformation mixture did not result in the 
growth of any colonies. This technique for re-streaking the putative integrants was 
repeated a second time with identical results. It can be inferred from this that the G418r 
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cassette was integrated successfully and could only be integrated in the presence of all 
four parts of this integration cassette, further suggesting that all four parts were 
integrated successfully. To confirm this integration, genomic DNA was extracted from 
multiple colonies corresponding to unique colonies from the initial transformation plate. 
PCR was undertaken to confirm the presence of the integration construct within Site 16. 
Primers selected to amplify the entirety of the Site 16 region, external to the homology 
sequence of the integration cassette, were expected to amplify a ~1500 bp region of 
Site 16 in unintegrated CEN.PK 13D, and amplify a ~3500 bp region of Site 16 if 
integration of the complete construct was successful. As is shown in Figure 3-8, 
although a clean 3500 bp band could not be obtained from the putative integrants, they 
showed the same streaked pattern of amplification as the flow-cytometry verified 
integrant F16TDH3YEGFP, with the size amplified DNA appearing to have an upper 
limit of ~3500 bp. Most notably, the same primers were able to amplify a ~1500 bp band 
from the background strain CEN.PK 13D.  The ~1800 bp G418r cassette was also 
amplified from these genomic DNA extractions in those colonies selected for further 
testing, as well as the ~2000 bp pRCGFPATTBP cassette. One of the integrants gives 
an inconsistent PCR amplification profile, where the G418r cassette and reporter 
construct amplifications work, but the reactions using primers 33 and 38, and 38 and 39 
failed. This is likely due to a failure of the PCR amplification due for practical regions, 
not necessarily because the integrant contained two of the targeted sequences but not 
the other two. In any case, five of the six integrants shown are positive for all four of the 






Figure 3-9: Ethidium bromide stained agarose gel images of Site 16 integration PCR characterization. 
Wells are, from left to right, M: Generuler 1 Kb Plus DNA marker, (-): CEN.PK 13D background strain 
(Negative control), (+): F16TDH3YEGFP (Positive Control), (--): No Template Control (sterilized MilliQ 
water used as template), 1-6: Putative F16RCGFPATTBP integrants. A: Primers 33 and 38 amplifying 
anything between the borders of Site 16. B: Primers 35 and 36 amplifying the G418 resistance 
cassette. C: Primers 39 and 40 amplifying the RCGFPATTBP cassette. D: Primers 39 and 38 




Fluorometry of F16TDH3YEGFP, BXBHA_RCGFPATTBP, CEN.PK113-13D, and 
three colonies of F16RCGFPATTBP_BXBHA show that although strong GFP 
fluorescence was detectable from F16TDH3YEGFP integrant, and more modest 
fluorescence could be detected from BXBHA_RCGFPATTBP grown in galactose using 
this instrument, no fluorescence could be detected from any of the tested 
F16RCGFPATTBP_BXBHA clones grown in glucose or galactose, and no evidence for 
inversion of the integrated RCGFPATTBP construct could be detected. The results of 
this fluorometry analysis is shown in Figures 3-9 and 3-10. 
 
 
Figure 3-10: Fluorescence of F16RCGFPATTBP integrants + BXBHA. Microtiter plate fluorometry of 
CEN.PK 13D integrated with RCGFPATTBP as well as those putative integrants also bearing the 
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Att sites, as well as TECAN fluorometry of plasmid borne RCGFPATTBP + BXBInt. 
 
 
Figure 3-11: Fluorometry of integrated RCGFPATTBP cassette compared to plasmid borne 
RCGFPATTBP cassette. TECAN fluorometry of CEN.PK 13D integrated with pRCGFPATTBP as well 
as those putative integrants also bearing the pBXBHA plasmid. Shown also is TECAN fluorometry of 
plasmid borne pRCGFPATTBP and pBXBHA.  
 
CHAPTER 4: DISCUSSION 
4.1: IMPACT OF ATT SITES ON YEGFP EXPRESSION 
If DNA inversion is to be a practical method for gene expression control for the 
purposes of synthetic biology or metabolic engineering, it would be ideal if the sites 
themselves didn’t interfere with the production of the gene that they are meant to 
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assays of this thesis, there is such interference. The reduction of expression that comes 
from introducing recombination sites between the coding sequence and the regulatory 
elements is not surprising in the light of the scanning model of eukaryotic translation, 
reviewed in Kozak.66 In brief, translation of a gene is initiated when eukaryotic initiation 
factors (eIFs) bind to the 5’ 7-methyllguanosine cap and sometimes the 5’ Untranslated 
Region (5’ UTR) of the mRNA transcript, thus recruiting the ribosome to the 5’ UTR 
where it will “scan” the transcript until it encounters a start codon which will truly initiate 
protein synthesis.66 It would stand to reason that adding extraneous (from the 
perspective of protein synthesis) sequence between the Translation Start Site (TSS) 
and the start codon may interfere with the rate of protein synthesis from a transcript. It is 
hypothesized that the low levels of fluorescence deriving from the YEGFPATTBP and 
YEGFPATTRL strains is the result of increased stability of RNA hairpins between the 
TSS and the start codon. Analysis of the secondary structure for the TSS of TDH3, the 
AttB and AttR sites, and the first 80 bases of the yeGFP ORF was undertaken using the 
mFold RNA folding prediction software (unafold.rna.albany.edu). Figure 4-1 shows that 
the AttB site forms a highly stable hairpin structure, and the AttR site is also predicted to 
form a slightly less energetically favourable hairpin, although still significantly greater 
















 Figure 4-1: RNA secondary structure of Att Sites. mFold analysis and free energy of the predicted 5’ 
Untranslated Region (UTR) and first 40 nt of the ORF of the pTDH3YEGFP, pYEGFPATTBP, and 
pYEGFPATTRL predicted transcripts. There is a correlation between hairpin stability and decreased 




Previous work with engineered expression systems shows that interposing 
sequences with a high degree of secondary structure between promoter elements and 
ORFs in the 5’ UTR of S. cerevisiae transcripts attenuates the activity of reporter 
constructs dramatically irrespective of transcript abundance,67 in relation to the 
thermodynamic stability of the secondary structure formed.68 Increasing the secondary 
structure of sequences immediately upstream of the AUG start codon have the greatest 
effect on protein abundance, as these secondary structures are likely to impede 
ribosomal scanning and initiation of peptide synthesis.69 
 
 
The secondary structures of the AttB and AttP recognition sequences of the BXB 
integrase may be problematic for its use as a tool for metabolic engineering. The 
attenuation of protein levels compared to the pTDH3YEGFP control is significant, 
measured at a ten-fold reduction in GFP fluorescence for AttR/L and 100-fold reduction 
of GFP expression for AttB/P. One might easily consider based on classical Michaelis-
Menten kinetics that lowering the concentration of an enzyme within a cell would lower 
the Vmax of the reaction which that enzyme catalyzes, and thus reducing the overall rate 
of that reaction. This could be problematic for metabolic engineering, which aims to 
increase the rate of formation of some valuable metabolic product. Adding Att sites 
immediately upstream of a weak promoter might be even more problematic, as the 
abundance of protein may be reduced to levels too low for efficient enzymatic 
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conversion. However, optimizing the rate of formation of the product of a multi-enzyme 
pathway does not always require high rates of reaction at every step in that pathway. 
Reactions which form toxic by-products or which are susceptible to product inhibition 
need not be upregulated. Metabolic engineering depends on having a wide range of 
regulatory elements available to optimize carbon flux by fine-tuning the expression 
levels of multiple enzymes within a pathway. Adding the BXB integrase Att sites 
immediately upstream of a promoter may not be appropriate in situations where very 
high levels of protein are required for optimization, but may not have a deleterious effect 
if the BXB-regulated step does not require a high rate of reaction. It may also be 
possible that taking into account the attenuation of expression that comes from 
interposing Att sites between promoter and ORF would allow for predictable metabolic 
engineering. It may even be desirable. It has been suggested that increasing mRNA 
secondary structure immediately upstream of an ORF by adding leader sequences 
would be a method to predictably fine-tune gene expression, as modulating the stability 
of mRNA secondary structure would allow for more predictable expression modulation 
than saturation mutagenesis of promoter elements.70 If the effects of mRNA secondary 
structure on protein levels were quantified for a particular Att site, then experiments 
which depend on quantifying protein concentrations might not necessarily be 
incompatible with serine integrase-mediated gene control.  
 It may be possible to recover the ablation of expression caused by interpolating 
the Att sites between the TDH3 promoter and the following coding sequence. The 
argument put forward in this thesis and in other work involved with inserting sequences 
between promoters and reporter coding sequence initiation sites68 is that this inhibition 
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of gene expression occurs at the level of translation. This hypothesis would state that 
increased secondary structure in the 5’UTR immediately upstream of the translation 
initiation site interferes either with the translation pre-initiation complex scanning the 
transcript and recognizing translational initiation sites, or interferes with the ribosome 
binding to the transcript at the correct initiation site. In either case, gene expression 
levels may be recovered to the same level as the wild-type promoter by adding an 
additional Internal Ribosome Entry Site (IRES) such as the YAP1 yeast IRES71 or by 
adding additional Kozak sequences between the Att site and the translation initiation 
site so that the linear order of regulatory elements would be Promoter-Att Site-
IRES/Kozak sequence-Coding Sequence rather than Promoter-Att Site -Coding 
Sequence. If this supposition about the inhibitory effects of Att sites immediately 
upstream of the GFP coding sequence in the pRCGFPATTBP construct is correct, it 
may be possible to utilize serine integrase mediated inversion in vivo without reducing 
gene expression levels of the regulated gene. While this experiment raises some 
troubling questions about the use of BXBInt as a tool for gene expression control and 
metabolic engineering, the levels of fluorescence from the YEGFPATTRL strain indicate 
that it is possible to detect fluorescence from an inverted yeGFP ORF as would occur if 
pRCGFPATTBP was inverted by BXBInt.  
 
4.2: ACTIVATION OF EXPRESSION BY DNA INVERSION 
Gene activation mediated by DNA inversion is one of the main criteria for 
success of this enzyme’s function in S. cerevisiae. Developing a system of gene 
expression control based on genetic memory requires this function. It was shown in 
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Section 3.4 that the expression of a yeGFP reporter cloned into a plasmid in the reverse 
compliment orientation with respect to a promoter could be activated upon induction of 
expression of BXBInt in S. cerevisiae. This indicates that the DNA of the yeGFP ORF 
was successfully inverted in the plasmid borne construct, which agrees with the findings 
from a similarly assembled construct expressed in E. coli.30 This is a welcome result for 
the prospect of using this recombinase class in eukaryotic cells, and its success was not 
necessarily a foregone conclusion. The main possible barrier to the function of BXBInt 
in S. cerevisiae is the nucleus of the cell. Given that maintenance and replication of 
plasmid DNA is localized to the nucleus and protein synthesis occurs in the cytoplasm, 
it may have been possible that BXBInt would not have access to plasmid borne Att sites 
sequestered in the nucleus. While experiments have shown that BXBInt could catalyze 
integration into and deletion from chromosomal DNA in other eukaryotic species,42,72 
DNA inversion catalyzed by BXBInt has not been previously demonstrated. The fact that 
there is no significant increase in the capacity for BXBInt to catalyze inversion when 
given C-terminal Nuclear Localization Sequences further supports the idea that the 
nucleus provides no barrier between this recombinase and its DNA substrates. 
The results of the time course experiment shown in Figure 3-4 provide some 
interesting insights into the kinetics of BXBInt’s inversion activity in yeast. Expression of 
GFP is undetectable by flow cytometry an hour after induction, with FL1 values being 
equal to both BXBHA strain and the RCGFPATTBP strain. The expression of GFP is 
detectable at 3 hrs, and reaches a maximum value at 5 hrs. Twenty-four hrs after 
transfer to the induction medium the value of detectable GFP fluorescence decreases 
slightly. This decrease in fluorescence is likely insignificant and could be attributed to 
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loss of the plasmid amongst some individuals within the culture as opposed to any 
alteration of the expression levels of the reporter construct itself. Results in Figure 3-5 
shows the same experiment over a longer timescale, where GFP levels were measured 
at 24 and 72 hrs of batch culture, after which cultures were back diluted 1/5000 in fresh 
media and allowed to grow for a further 24 hrs. The fluorescence of the galactose 
induced BXBHA_RCGFPATTBP culture shows a slight reduction in GFP expression at 
each time point, although the average GFP levels of each time point fall within the 
standard deviation of the measured replicates. It can be concluded that the expression 
level of GFP of inverted reporter constructs is stable over the course of a multiple-day 
small-scale batch culture. The fact that GFP fluorescence remains constant after back 
dilution into fresh media and overnight growth also shows that the inverted plasmid can 
be maintained in its inverted state over the course of several generations in the 
presence of the inducer. This is a demonstration of the heritability trait of the serine 
integrase inversion system, that there is no alteration in expression of inverted DNA 
after being allowed to replicate and pass from mother to daughter cell. 
 
4.3:  DEACTIVATION OF GENE EXPRESSION BY BXBINT MEDIATED INVERSION 
OF YEGFPATTBP 
 If DNA Inversion is to function as a truly bi-directional and multipurpose tool for 
gene expression control, it should be possible to activate gene expression using DNA 
inversion and also to completely de-activate it. DNA inversion should proceed in the 
same manner regardless of what the starting orientation of the DNA is. To test for gene 
de-activation, constructs were developed which would test the ability of BXBInt 
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inversion to de-activate gene expression. The results from Section 3.3, showed that 
expression of a yeGFP coding sequence regulated by the BXBInt AttB and AttP sites 
could not be turned off to any significant degree by BXBInt mediated inversion. It should 
be noted that this form of inversion has not been demonstrated in other works 
describing the activities of LSTRs. Even after a multiple day induction of the BXBInt 
plasmid, yeGFP expression was maintained at the same level as strains lacking the 
BXBInt plasmid and strains that were not induced with galactose. Moreover, average 
yeGFP were maintained even after cultures were back diluted into fresh media and 
were allowed to grow exponentially for 24 hrs, excluding the possibility that yeGFP 
expression had been turned off but that the yeGFP protein had simply not degraded 
over the course of the experiment. Looking at the percentage of cells that display GFP 
fluorescence above the background level shows a small decrease in the number of cells 
which have no significant GFP fluorescent compared to the same reporter construct 
without the integrase. This could be seen as a decrease of gene expression caused by 
the inversion of the YEGFPATTBP reporter construct, but it is not nearly as clear cut as 
an effect as is seen when gene expression is turned on by DNA inversion as is seen in 
the strain BXBHA_RCGFPATTBP. The latter shows an increase in the number of 
fluorescent cells from zero percent to over fifty percent when integrase expression is 
induced. This means that over half of the cells that were “Off” in terms of GFP 
expression became “On” due to the integrase. It would be expected that for the strain 
BXBHA_YEGFPATTBP at least half of the cells that start out as “On” be turned “Off” 
due to DNA inversion. It is hard to say whether this effect was observed based solely on 
GFP fluorescence due to the large variation between biological replicates and 
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considering the confounding variable of GFP fluorescence being less in the 
YEGFPATTBP strain (which lacks the integrase plasmid) when grown in galactose 
compared to glucose. 
 If DNA inversion does occur in the strain BXBHA_YEGFPATTBP, the assay 
presented in this thesis is not capable of observing it. A logical next step to detect DNA 
inversion would be to look at the physical structure of the reporter construct plasmid. It 
would be possible to design an assay based on DNA sequencing, quantitative PCR, 
restriction mapping, or Single Nucleotide Polymorphism analysis of the reporter 
constructs would allow for quantification of physical DNA inversion events in the case 
where only a minority of a cellular population actually experiences DNA inversion. 
Without the data from these assays, all that can be said now is that the collective effect 
on the gene expression of a population of cells, is much less when DNA is inverted from 
“On” to “Off” than it is when DNA is inverted from “Off” to “On”, and this asymmetry of 
function needs an explanation. It is the argument of the author that this explanation is 
that the inversion mediated by BXBInt does not occur to the same extent when 
activating and de-activating gene expression. 
 It could be a possibility that DNA inversion is only occurring in a small proportion 
of the cells being tested in these assays. With this in mind Figure 3-8 illustrates the 
percentage of individual cells that show GFP fluorescence above background levels. 
This figure shows the same pattern as that seen in Figure 3-7, showing the average 
GFP fluorescence of the population of cells. There appears to be a general decrease in 
GFP fluorescence when YEGFPATTBP is grown in galactose for 72 hours and then 
grown for an additional 14 hours in glucose (66.7% to 53.54%, a 13% decrease) when 
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compared to that strain grown glucose for 72 hours and then back diluted into glucose. 
The decrease in fluorescence is also seen in BXBHA_YEGFPATTBP (62.3% to 32.1%, 
a 30% decrease), and the decrease is slightly more than that seen in YEGFPATTBP. 
The difference in the decrease of fluorescing cells is around 17%. It is difficult to say 
whether this represents an actual incidence of DNA inversion causing the de-activation 
of GFP expression. The variation in the proportion of fluorescent cells between 
replicates is quite large, such that the gap between the upper error bar of 
BXBHA_YEGFPATTBP Galactose 96 hour back diluted and the lower error bar of 
YEGFPATTBP Galactose 96 hour back diluted is 11%. This would be the minimum 
proportion of cells whose decrease in fluorescence could be attributed to DNA inversion 
mediated by BXBInt. This figure seems low, considering that when 
BXBHA_RCGFPATTBP is grown in glucose and galactose, the proportion of cells that 
fluoresce above background goes from 0% to over 50% within 24 hours. This latter fact 
seems to indicate that DNA inversion occurs in at least 50% of the cells that bear the 
integrase and reporter construct plasmids. If DNA inversion occurred at the same 
frequency in the strain BXBHA_YEGFPATTBP, the difference in the decrease of 
fluorescing cells should be at least half of the number of cells that fluoresce above 
background without the presence of BXBInt. In other words, if 70% of YEGFPATTBP 
cells fluoresce when grown in glucose under ideal conditions, the difference between 
any decrease in fluorescence between YEGFPATTBP and BXBHA_YEGFPATTBP 
should be at least 35%. Since the observed difference is between 11% and 17% over 
the course of 96 hours, it would be premature to conclude that any decrease in 
fluorescence was caused by BXBInt expression. In any case, looking at the average 
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GFP fluorescence in figure 3-7 shows that the bulk effect of any DNA inversion is 
minimal at best. 
The most likely explanation for the lack of conclusive is that the pYEGFPATTBP 
plasmid was unmodified by BXBInt in this experiment. This finding is surprising given 
the previous research into BXBInt and other LSTRs, which have identified the presence 
of AttB and AttP sites as sufficient conditions for inversion. There are a number of 
possible explanations as to why this may have happened. Firstly, there may be some 
experimental error preventing BXBInt mediated inversion. Although the pYEGFPATTBP 
plasmid was sequenced prior to being transformed into the double auxotroph alongside 
the BXBInt plasmid, and the BXBInt plasmid was used to transform the pRCGFPATTBP 
plasmid bearing strain as a positive control for plasmid inversion, it is possible that a 
rare mutation altered one of the Att sites.  It is possible that recombination occurred 
between the two plasmids, which may have altered the GAL1 regulated BXBInt 
cassette. Random mutation seems unlikely, as the same phenomenon was observed in 
multiple biological replicates of BXBHA_YEGFPATTBP, and lack of expression of the 
BXBInt protein also seems unlikely, as the same plasmid was able to cause 
recombination in the pRCGFPATTBP bearing strain. There may be a mechanistic 
reason why this inversion was unable to occur. It could be that elements of transcription 
initiation factors and RNA polymerase binding to plasmid DNA interferes with BXBInt 
binding to the Att sites in such a way that only occurs when AttB is directly proximal to 
the start codon of yeGFP.  Inversion occurs when AttB is distant from any possible start 
codon, as is the case when the reporter cassette of pRCGFPATTBP is inverted, and 
transcription and translation of the reporter ORF occurs when AttR is proximal to the 
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start codon, as is the case when RCGFPATTBP has been inverted. However, any 
proteins that bind to the pYEGFPATTBP construct in the region of the Att Sites in order 
to inhibit BXBInt, such as transcription factors, which bind to the TDH3 promoter or 
ENO2 terminator would also bind to those regulatory elements of the RCGFPATTBP 
reporter cassette without inhibiting inversion. This molecular crowding hypothesis might 
not provide a completely coherent explanation for the asymmetry between the two kinds 
of inversion activity, but it is clear that if the inability of BXBInt to invert DNA that is 
being actively transcribed is not an experimental error or caused by a rare mutation, that 
it is a major drawback for the use of this enzyme as a universal tool for genetic 
engineering. 
 
4.4: INTEGRATION OF RCGFPATTBP 
 Integration of the reporter cassette from pRCGFPATTBP into the yeast 
chromosome also poses difficulties for the use of BXBInt as a genetic engineering tool. 
It would be a useful tool for synthetic biologists and metabolic engineers to re-arrange 
the structure of chromosomal DNA in vivo in a dynamic manner, and possibly control 
gene expression through this mechanism. There are a number of possible explanations 
as to why BXBInt mediated inversion of chromosomally integrated DNA could not be 
observed. The first plausible explanation is failure to successfully integrate the 
F16RCGFPATTBP integration construct into Flagfeldt site 16. There is evidence to 
suggest that the RCGFPATTBP cassette was integrated successfully, but this evidence 
is not absolutely conclusive. The design of the integration cassette was based on 
homologous recombination of four amplified fragments of DNA, which had 40 base-pair 
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regions of homology to their adjacent fragments. The sequence of amplicons is 
structured thusly: Site 16 homology region Up-G418 cassette-RCGFPATTBP cassette-
Site 16 homology region Down. Negative control transformations which contained three 
of these four amplicons were sensitive to G418, indicating that integration cannot occur 
unless all four amplicons are present in order to bridge the two chromosomal homology 
regions into one cohesive integration construct. Moreover, a parallel integration where 
the pRCGFPATTBP cassette was replaced by the pTDH3YEGFP expression cassette 
with the same linkers joining it to the G418 cassette and chromosomal homology region 
was resulted in G418 resistant colonies, and fluorometry of these colonies showed high 
levels of yeGFP expression after two rounds of re-streaking in a large proportion of 
colonies tested. Thus there is circumstantial evidence that acquiring the G418r cassette 
also means that the pRCGFPATTBP cassette has also been integrated. This, alongside 
the pattern of amplicons obtained from PCR analysis of the integration site being what 
would be expected from a successful integration of the pRCGFPATTBP construct, 
provides strong evidence to suggest that the construct integrated successfully but failed 
to invert. 
 The lack of evidence for inversion of chromosomally integrated Att sites is a 
major impediment to the use of the BXB Integrase as a mechanism for genetic memory 
in yeast. This result, if correct, would exclude the use of this enzyme from being used to 
establish a genetic memory based expression system on the chromosome, which would 
be the ideal location for experiments seeking to establish stable genetic expression for 
the purposes of metabolic engineering, pathway optimization, or large-scale 
fermentation. Combined with the selective activity towards plasmid based DNA, the 
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options towards which this enzyme could be used in S. cerevisiae appear to be more 
limited than they are for bacterial strains.  
CHAPTER 5: CONCLUSIONS 
ACTIVITY OF BXBINT IN SACCHAROMYCES CEREVISIAE. 
 The expression of BXBInt in S. cerevisiae was shown to catalyze dynamic, in 
vivo inversion of the yeGFP reporter cassette in this study. This is a useful result for 
those interested in utilizing this enzyme for genetic manipulation in S. cerevisiae, but 
there are certainly questions that remain to be answer regarding the heterologous 
expression of serine recombinases. The mycobacteriophage BXB1 integrase was 
selected for this study in part due to the fact that it had been previously shown to 
catalyze integration when expressed heterologously in eukaryotic organisms, 39,40,42 and 
inversion of DNA when expressed heterologously in E. coli.30 However, Xu et al. made 
the observation that although they screened 15 large serine-type recombinases for 
integration activity in human cell lines, not all of these recombinases showed the same 
rate of recombination or specificity of integration. While the site-specific and orthogonal 
nature of Integrase/Att site recombination provide the promise for multiplex 
simultaneous recombination events in S. cerevisiae, this thesis failed to investigate 
other members of this diverse family of enzymes to compare their ability to catalyze 
DNA inversion, or investigate the possibility of multiplex simultaneous in vivo inversion 
invents. This property of serine integrases remains to be exploited to its full potential.  
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RESTRAINTS ON BXBINT INVERSION 
 This thesis provides some promising insights into the activity of BXBInt in S. 
cerevisiae, but also highlights some significant restraints on its potential use for genetic 
engineering of protein expression systems. Serine integrase Att sites can be easily 
adapted to homology based cloning platforms such as DNA Assembler or Gibson 
Assembly. It seems as though nuclear localization provides no barrier to the binding of 
the enzyme to its cognate Att sites. And it was demonstrated that the activity of DNA 
inversion could occur through dynamic induction in living cells, with no noticeable 
background expression of the Att-regulated reporter. These properties of the BXBInt 
inversion system constructed for this thesis are desirable for synthetic biologists 
interested in in vivo genetic manipulation of eukaryotes 
However, there are detriments of this system, which must be addressed in order 
to optimize serine integrase based gene expression control. Quantification of the 
expression of a yeGFP reporter regulated by the BXBInt Att sites immediately adjacent 
to the reporter ORF showed a significant reduction of expression, probably caused by 
increased secondary structure of the mRNA transcript of this reporter preventing 
efficient translation. This is a significant drawback to the use of this recombination 
system as it was constructed in this study, as any application, which relied on 
expression of an integrase-regulated protein would obviously be negatively impacted. It 
may be possible that by adjusting the location of Att sites with respect to other elements 
of an expression cassette may restore the expression levels of the regulated protein. If 
the proposed hypothesis that increased secondary structure in mRNA transcripts 
prevents efficient recognition of start codons by the ribosome is correct, it would be 
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reasonable to suggest that adding spacer sequences between the Att site and start 
codon would increase the amount of functional protein within the cell. Studying the 
effects of Att site location within a reporter cassette would be a reasonable next step in 
the development of BXBInt as a tool for gene expression control 
 This thesis also made an interesting observation as to the directionality of 
DNA inversion catalyzed by BXBInt. While it was demonstrated that gene expression 
could be activated by DNA Inversion, deactivation of gene expression catalyzed by DNA 
inversion of a yeGFP cassette from a translationally active orientation to the reverse 
compliment orientation was not observed over the course of several days of exponential 
growth. This could be an indication that the context of the sequences adjacent to the Att 
sites are relevant to the activity of the recombinase. There may be some element of the 
ORF used in this study that inhibits recombination between AttP and AttB when placed 
in the “forward” orientation with respect to the promoter and these two sequences. The 
structure of the RCGFPATTBP reporter cassette and the proposed mechanism for 
mRNA transcription in yeast implies that is that the yeGFP mRNA is still transcribed 
when in the reverse compliment orientation, but not in an orientation that would result in 
translation of a functional yeGFP protein. After inversion, the yeGFP mRNA is 
transcribed with the ORF in a translationally active orientation. For the FYEGFPATTBP 
plasmid, it is clear that the yeGFP reporter is both transcribed and translated to form an 
active yeGFP, and would potentially transcribe an mRNA after inversion with a 
translationally inactive reverse compliment yeGFP ORF. There should be no difference 
in the ability of BXBInt to access the AttP and AttB sites between both plasmids. It could 
be that the forward orientation sequence of the yeGFP ORF adjacent to the Att sites 
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recruits some DNA binding proteins to the plasmid which exclude the Integrase from 
accessing the Att sites which do not bind to the reverse compliment yeGFP cassette 
adjacent to the Att sites. Using alternate reporters in place of yeGFP may support or 
refute this hypothesis, or attempting to co-precipitate these DNA sequences and DNA 
binding proteins. In any case, it can be said that DNA inversion by BXBInt may be 
dependent on the context of the sequence in which the Att sites are situated. More 
investigation is needed in order to develop a BXBInt as a truly versatile tool for dynamic 
gene expression or knockout. 
 
INVERSION OF CHROMOSOMAL DNA 
 The lack of evidence for inversion of chromosomally integrated Att sites is a 
further impediment for the development of BXBInt as a tool for genetic engineering. The 
higher-ordered structure and binding of structural proteins of genomic DNA compared to 
plasmid DNA functioning to prevent the efficient formation of an invertasome-like loop of 
DNA during DNA inversion may be a reasonable explanation for the lack of BXBInt 
activity. Engineering chromosomal DNA is an attractive strategy for large scale 
biotechnology applications, as the stability of integrated constructs is much greater than 
plasmid-borne constructs in large scale fermentation. These considerations together 
would significantly undermine the stated goal of this thesis, of developing a BXBInt-
mediated DNA inversion system as a form of genetic memory for the induction of genes 
in large-scale fermentation. However, if the hypothesis around the lack of inversion 
observed in the experiments described in Section 3.4 were to be shown invalid, then it 





 The experiments and observations described in this thesis highlight some 
limitations for the use of the BXB1 Integrase protein for synthetic biology and genome 
engineering in S. cerevisiae. This thesis represents the first published attempts to both 
activate and de-activate gene expression via DNA inversion, as well as the first 
attempts to invert chromosomal DNA of a eukaryotic organism, both of which were 
unsuccessful. It can be concluded from this these experiments that the universal 
application of serine integrases to perfectly perform complex, dynamic DNA 
manipulations may not be straightforward, and may require significant additional study 
and engineering if the goal of using DNA inversion as a form of genetic memory or as a 
device for synthetic biology is to be achieved using this enzymes or others like it.  
However, these experiments also suffer from significant limitations, namely that only 
one reporter and Att site construct was tested and only one Large Serine-type 
Recombinase family member was used to catalyze inversion. It is therefore quite 
difficult to draw definite conclusions about the activity, or lack thereof, of LSTRs and 
DNA inversion. The observation of activated gene expression of plasmid-based DNA in 
yeast is an encouraging result, but it is not enough to unreservedly recommend the use 
of BXBInt as a tool for multiplex dynamic gene expression control in this organism. 
Hopefully, the results of the experiments described in this thesis will serve to provide a 
starting point for further investigation into the use of this fascinating class of enzymes to 
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